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SUMMARY
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Since the original population study of angina pectoris which commenced in 
Framingham in 1949, there has been no contemporary study of this common disease 
in relation to incidence, clinical characteristic and prognosis. The overall objective 
of this study was to investigate new cases of angina in the population presenting for 
the first time with this symptom of coronary disease. Specifically the objectives were 
to measure the clinical incidence of angina and to assess the patients’ clinical 
characteristics with particular reference to ambulatory and exercise electrocardiography 
and the relationship of these physiological variables to prognosis.
A random sample of 17 general practices was drawn from within the boundary 
of the city of Southampton and all 117 general practitioners agreed to refer every new 
patient <  70 years with no previous CHD presenting for the first time with suspected 
angina to an open access chest pain service. Of 110 consecutive patients presenting 
with typical angina, 70 were male and 40 female. The crude annual incidence rate 
(95 % confidence interval) of angina pectoris in this representative population sample 
was 0.83 (0.66, 1.0) per thousand population aged 31-70 years; for men and women 
the rates were 1.13 (0.85, 1.40) and 0.53 (0.33, 0.72) respectively. The incidence 
of angina pectoris in the United Kingdom is estimated from this study to be at least 
22,600 patients per annum. Ninety-six of 110 angina patients and 95 age, sex and 
practice matched asymptomatic healthy controls underwent 24 hour ambulatory ECG 
monitoring prior to antianginal therapy. All tapes were analysed blind. Ischaemic ST 
segment depression, defined as > 1mm horizontal/downsloping shift from baseline at 
J+80 msec lasting > 1 min, was prevalent in 34 of 64 (53%) men with angina vs 7 
of 59 (12%) male controls, and in 16 of 32 (50%) women with angina vs 2 of 36 
(6%) controls. In logistic regression analysis, serum cholesterol (p =  0.02) and 
exercise ischaemia (p = 0.003) were independently associated with the presence of 
ambulatory ischaemia in men with angina, but only the latter was significant in 
women; this may reflect a different pathophysiological basis for ambulatory ischaemia 
in women. At a median follow-up of 15.8 (range 7-30) months, angina remitted 
spontaneously in 12 (11%) patients, 20 (18%) patients underwent revascularisation, 
8 (8%) sustained a non-fatal myocardial infarction, and 4 (4%) died. In Kaplan-Meier 
survival analysis, there was no significant difference in event-free survival from
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coronary angioplasty, coronary artery bypass grafting, myocardial infarction or death 
between patients with and without ambulatory ischaemia (66% vs 72%, p=NS).
This is the first contemporary population study of new patients with angina 
pectoris since the advent of widespread non invasive electrocardiographic assessment, 
coronary arteriography and revascularisation. Angina is common and while in the 
majority of patients the resting electrocardiogram is normal at presentation, exercise 
induced ischaemia (>  1mm) is found in 64% (42 of 66) of men and in 57% (21 of 
37) of women. Ambulatory ischaemia is present in over half of new patients 
presenting with angina, but appears to be of no prognostic value. The prognosis of 
incident angina despite appropriate cardiological assessment and management is not 
benign. The study thus raises an important question which should be answered by a 
randomised controlled trial - does early cardiological assessment and coronary 
revascularisation reduce the morbidity and mortality of incident angina pectoris?
CHAPTER 1 
INTRODUCTION
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Cardiovascular disease is the most frequent cause of death in the United Kingdom. 
Coronary heart disease (CHD) accounts for 65 % of cardiovascular deaths in men and 
for about half of deaths in women (OPCS, 1989). In both sexes up to the age of 65 
years, cardiovascular diseases account for up to a quarter of all years of working life 
lost (OPCS, 1987).
Coronary heart disease commonly presents as angina pectoris. Angina affects 
over one million men and women under 65 years age in the United Kingdom (Shaper, 
1984; Smith, 1990). It is the initial clinical manifestation of CHD in over a third of 
men and in about two-thirds of women (Kannel, 1972). The first description of angina 
pectoris as a clinical syndrome over 200 years ago (Heberden, 1772) was followed by 
the anatomical association with coronary atheroma and establishment of the ischaemic 
theory of angina (Proudfit, 1983). It is now recognised that although there is a close 
relationship between angina, myocardial ischaemia and coronary atherosclerosis, any 
one of these three can exist on its own, or in combination with one or both of the 
other two entities.
The majority of patients with angina pectoris present to their general practitioner 
and are managed in the community but little is known about the frequency, prognosis 
and optimum investigation and management of this manifestation of coronary disease 
in the population. Prevalence of angina has been estimated in many cross-sectional 
surveys using questionnaires, but incidence is less well documented and there has been 
no contemporary incidence study since the advent of revascularisation. Clinical 
characteristics of patients presenting with angina pectoris in the general population 
beyond a resting ECG have not been defined.
Electrocardiography - resting, exercise and ambulatory - features foremost 
among the investigations for patients presenting with angina pectoris. Continuous 
ambulatory electrocardiographic monitoring was introduced nearly two decades ago, 
yet despite extensive investigation, its frequency and prognostic value in patients 
presenting with angina pectoris in the general population have not been documented.
This chapter reviews the prevalence and incidence of angina pectoris and the 
frequency and prognostic significance of resting, exercise and in particular, 
ambulatory electrocardiography in patients with angina. Careful attention is paid to 
the method of patient selection in the reported studies to assess whether their results 
can be applied to the generality of stable angina patients encountered in clinical
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practice. The limitations of available data are discussed, and the objectives of the 
present study are outlined.
1.1 Prevalence of Angina
Prevalence of angina has been estimated in three large studies (Table 1.1) using a 
chest pain questionnaire and ranges from 4.8% in middle-aged men to 8.5% in 
women. Epidemiological methods have to be simple and cheap so most surveys are 
limited to captive populations in particular employments (Reid et al, 1974) and to 
specific age groups (Shaper et al, 1984; Smith et al, 1990).
Whitehall (1967-69) BRHS*
(1978-80)
SHHSf
(1984-86)
Patients Civil Service random, general 
practice
random, general 
practice.
Sex Men Men Men and women
Age (years) 40-64 40-59 40-59
n = 18,403 7,735 10,359
Prevalence (%) 4.8 4.8 men 6.3 
women 8.5
* BRHS =  British Regional Heart Study 
t  SHHS =  Scottish Heart Health Study
Table 1.1 Prevalence of angina pectoris
Two other community based surveys of patients under treatment for ischaemic 
heart disease also report angina prevalence. In a 4-month survey in 1979 by the Royal 
College of General Practitioners, 51 general practitioners in Newcastle covering a 
population of 125,000 recorded patients aged 30-59 years that they treated for angina, 
and concluded that prevalence in their population was 1.1% (RCGP research 
committee, 1982). The methods used in this survey include memory recall to identify 
treated cases and a diagnosis which includes a ‘suggestive’ history of angina. Both 
methods have obvious limitations.
A more reliable estimate of prevalence comes from a survey of prescriptions for 
nitrates in Nottingham (population 612,800). During a 6-month period in 1984-5 
15,451 nitrate prescriptions for 6,856 patients were identified (Cannon, 1988). 
Estimated prevalence of angina was 1.5% in men under 65 years age and 0.6% in
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women under 60 years. However this may be an overestimate of the true prevalence 
as the diagnosis of angina examined in a sub sample of patients was incorrect in a 
significant proportion. In that study, prevalence increased sharply in men over the age 
of 65 years to 7.1% and to 4.4% in women over 60 years old.
1.2 Incidence of Angina
Incidence of angina pectoris has proved difficult to measure. To date, only the 
Framingham study has estimated incidence in a representative sample of men and 
women in the general population (Kannel, 1972). A cohort of 5,127 residents of 
Framingham, USA underwent biennial clinical examination between 1949 and 1966. 
From 303 cases of angina arising in men and women aged 33 to 69 years over this 
period, incidence estimates in men ranged between 2/1000 population/year in the 40- 
44 year age group to 11/1000/year in the 55-59 year age group. Corresponding rates 
in women were 0.5/1000/year to 2 /1000/year.
The incidence of angina has also been reported in three other areas (Table 1.2) - 
in an occupational cohort of 9,764 Israeli male civil service and municipal employees 
(Medalie, 1976), in a single London general practice population (Fry, 1976) and in 
a population of men from selected general practices in Edinburgh with easy access to 
a special clinic (Duncan, 1976).
No conclusions about the real extent of variation in incidence rates of angina can 
be drawn from these reports because of wide differences in composition and size of 
patient populations, method of diagnosis and period of study. The most recent 
incidence estimate available is from a study reported 17 years ago. No current data 
is available.
1.3 Resting Electrocardiography
Due to a lack of population based studies of angina pectoris, information about clinical 
and electrocardiographic (ECG) characteristics in the generality of patients with this 
disease is limited. Available evidence suggests that less than 20% of patients 
receiving medical treatment for angina from general practitioners are referred for 
hospital investigation (Cannon, 1988). Extrapolation of results from hospital patients 
to the general population of angina patients is therefore inappropriate because selection
16
study subjects population annual
period at risk incidence*
Framingham
USAa
1949-66 men and women 
33-69 yrs
5,130 4.2
Israelb 1963-68 men
over 40 yrs
9,764 5.7
London GP0 
UK
1950-75 men and women 
over 40 yrs
2,755 5.0
Edinburgh4,6
UK
1970-72 men
35-69 yrs
28,400 1.8
* crude rate per thousand population at risk
Table 1.2 Reported incidence of angina pectoris in selected populations 
1949-72 (a Kannel, 1972; b Medalie, 1976; c Fry, 1976; d  Fulton, 1972; 
e Duncan, 1976)
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bias leads to spurious associations which cannot be compensated for even by very 
large studies (Evans, 1991).
The frequency of ischaemic changes on resting electrocardiography have been 
reported in two population based prevalence studies of patients with angina. Major 
resting electrocardiographic abnormalities (flat or downsloping ST segment depression 
of >  0.6mm or T wave inversion) in recordings using only three orthogonal leads 
were evident in 5.2% of 40-59 year old men in the British Regional Heart Study who 
had definite angina diagnosed by questionnaire (Shaper, 1984). This compared to 
a prevalence of 2.6% for similar ECG abnormalities in asymptomatic men.
The Whitehall study showed that although there was a significant increase in 5- 
year coronary heart disease mortality in men with symptoms and resting limb lead 
electrocardiographic abnormalities compared to asymptomatic men with such 
abnormalities, the 5-year CHD mortality rate in men with either ECG abnormalities 
or chest pain was low at only around 3%. Interestingly, men with ECG abnormalities 
who were under the care of a doctor had up to fourfold higher age-adjusted CHD 
mortality rates compared with those who were not under medical care (Rose, 1978), 
suggesting that presentation per se to a doctor is associated with a worse prognosis 
regardless of questionnaire responses or ECG abnormalities.
Self selected presentation by patients to the primary care physician is thus the 
first stage in risk stratification of angina pectoris in the general population. An 
important implication of this observation is that patients diagnosed as having angina 
solely on the basis of responses to a chest pain questionnaire are a lower risk group 
than those who present to their general practitioner.
1.4 Ambulatory Electrocardiography
Transient ST segment depression associated with chest pain in active subjects was first 
described by Holter in 1961 (Holter, 1961), but due to concerns about reliability of 
the poor low frequency response of recorders, further research interest did not develop 
until the 1970s when Stem and Tzivoni described frequent transient episodes of ST 
segment depression during daily living activities, many of which not accompanied by 
chest pain (Stem, 1974). Since then, extensive research using ambulatory monitoring 
in selected patients with angina confirms that transient episodes of ST segment 
depression occur with and without chest pain (Selwyn, 1978; Deanfield, 1983; Shea,
1985; Cecchi, 1983; Mulcahy 1988).
Most studies of ambulatory ST segment monitoring are based on angina patients 
with positive exercise tests and angiographically proven coronary artery disease. In 
such patients, it is considered that ST segment changes often represent true ischaemia 
because of a high correlation with simultaneous perfusion defects on positron emission 
tomography (Deanfield, 1983 and 1984), myocardial dysfunction (Chierchia, 1983), 
and to a lesser extent with rises in pulmonary artery diastolic pressure (Levy, 1986). 
But data which directly correlates monitoring tracings with impaired myocardial 
perfusion to validate ST segment depression as representing the myocardial ischaemia 
are limited.
Variability
The inherent variability of ST segment response during daily living which clearly 
affects interpretation of clinical studies of ambulatory ischaemia has received limited 
attention (Khurmi, 1987; Deanfield, 1983; Nabel, 1988). In exercise test-positive 
patients with at least 5 episodes of typical angina per week, the reproducibility 
between two occasions of 24 hour monitoring 6 weeks apart was surprisingly good for 
the number, total duration and extent of ST segment depression recorded in the two 
leads CM5 and CC5 (Khurmi, 1987). However within and between patient variability 
was not quantified. By contrast, a marked day-to-day and long-term variability in the 
number of episodes of ST depression was reported in a study of 30 patients with 
similar characteristics (Deanfield, 1983), but not quantified.
The best quantitative assessment of variability was undertaken in 42 patients with 
stable angina and angiographically proven coronary artery disease who had at least one 
episode of ST depression during an initial 48 hour monitoring period (Nabel, 1988). 
A between patient variability contributed to 40% of the variance in frequency of 
episodes, and a similar variance within patients resulted from monitoring between 
different weeks. This large spontaneous variability was not normally distributed.
In all studies, monitoring was carried out at least twice on each patient using 
standard amplitude or frequency modulated equipment with an adequate frequency 
response and uniform criteria for the presence or absence of ischaemic ST segment 
change. In each case, a clear description of lead positioning was provided, and 
physicians verified abnormalities found during the test. All studies evaluated patients
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with known chronic stable angina and a positive exercise test. Antianginal medication 
was kept constant, but factors such as physical activity could not be controlled.
Based on these findings, Nabel and colleagues (1988) have proposed guidelines 
for how much change should be attributed to random variation and how much to 
treatment or progression of disease. The variability of ambulatory ischaemic changes 
in these select groups of hospital patients with frequent angina, may however be 
different from other unstudied clinical subgroups and the precise extent of variability 
in the general population of angina patients is not known.
Prevalence
The reported prevalence of ambulatory ischaemia in patients with angina pectoris 
ranges from 19% to 92% (Figure 1.1).
All studies include selected tertiary cardiac centre patients with a positive 
exercise test at low workloads (Campbell, 1086; Rocco, 1988; Mody, 1988; Tzivoni, 
1989; Deedwania, 1990), and with a history of a previous myocardial infarction in 
varying proportions (Cecchi, 1983; Von Amim, 1985; Quyyumi, 1987; Mulcahy, 
1988; Deedwania 1990). Almost all consist of patients with angiographically proven 
coronary artery disease on entry (Cecchi, 19832; Shea, 1985; Campbell, 1986; 
Mulcahy, 1988; Rocco, 1988; Tzivoni, 1989) or with disease severe enough to 
warrant angiography (Stem, 1974; Von Amim, 1985; Tzivoni, 1986; Quyyumi, 1987; 
Mody, 1988; Deedwania, 1990; Hoberg, 1990). With the exception of two studies, 
one where usual antianginal treatment was continued (Deedwania, 1990), and another 
where long acting nitrates and calcium antagonists were stopped but an unspecified 
number continued taking beta blockers (Von Amim, 1985), only short acting nitrates 
were used during the monitoring period. The duration of recording was 48 hours in 
some studies (Shea, 1985; Quyyumi, 1987; Mulcahy, 1988; Rocco, 1988), 24 hours 
in the rest, and not specified in one (Tzivoni, 1989).
In all of the above studies, ambulatory monitoring was performed on carefully 
selected patients referred for hospital investigation, so the true frequency of transient 
ischaemic episodes in unselected patients with stable angina pectoris remains unknown.
Prognosis
Likewise there are conflicting reports about the prognostic value of ambulatory ST
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segment analysis. Studies assessing the prognostic importance of ambulatory 
myocardial ischaemia in various subgroups of patients with stable coronary heart 
disease have varied from showing an independent predictive value of silent ischaemia 
for cardiac mortality (Deedwania, 1990), or for all cardiac events in the short term 
(Rocco, 1988; Tzivoni, 1989) but not for cardiac mortality and myocardial infarction 
in the long term (Yeung, 1991), to more recent studies showing a lack of prognostic 
value of ambulatory ischaemia (Mulcahy, 1992; Quyyumi, 1993).
Although the studies purportedly represent "unselected11 patients with stable 
angina, the study populations differ in many respects. The number of patients vary 
from 56 in a study in which the inclusion criterion of ‘at least one year of follow up’ 
suggests that it was retrospective (Tzivoni, 1989), to 172 in a prospective study of 
non-consecutively selected outpatients from two centres (Mulcahy, 1992). The 
proportion of men included ranges from 79% (Yeung, 1991) to 100% (Deedwania,
1990), and mean age varies from 58 to 63 years. Four of the five studies do not 
include consecutive patients (Rocco, 1988; Tzivoni, 1989; Yeung, 1991; Mulcahy, 
1992), and in the one that does, only 107 men were recruited over a twenty-one month 
period (Deedwania, 1990) reflecting selective inclusion of patients. Most cardiology 
clinics would probably assess several hundred patients with angina over this time 
course.
Like the prevalence studies discussed earlier, the prognostic studies also used 
similar selection criteria including an exercise test positive for ischaemia at low 
workloads (Rocco, 1988; Tzivoni, 1989; Deedwania, 1990; Yeung, 1991) and the 
presence of angina on exercise (Rocco, 1988; Yeung, 1991). A variable number of 
patients took antianginal therapy which was stopped prior to monitoring by some 
(Rocco, 1988; Yeung, 1991), but not others (Deedwania, 1990). The proportion of 
patients with a previous myocardial infarction varied from none (Tzivoni, 1989) to 
52% (Deedwania, 1990), and of patients with previous CABG from 13% (Mulcahy, 
1992) to 23% (Rocco, 1988).
Patient selection based on a low workload-positive exercise test may exaggerate 
the prognostic importance of ambulatory ischaemia, because a positive exercise test 
not only predicts the presence of ambulatory ischaemia (Campbell, 1986; Danza,
1991), but is also independently associated with reduced survival (Weiner, 1984; 
ECSSG, 1982). It follows therefore that in prognostic studies of ambulatory
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monitoring in which patients are selected on the basis of a low workload positive 
exercise test, the patients with angina who have a high probability of having detectable 
ischaemic episodes are also the ones most likely to experience a cardiac event. In 
such studies, patients who experience a cardiac event would have a higher frequency 
of demonstrable ambulatory ischaemia than patients not selected on the basis of a 
positive exercise test. This is indeed the case (Figure 1.2) and 67-100% of patients 
who experienced myocardial infarction or death in studies which included only 
exercise test positive patients had demonstrable ambulatory ischaemia (Rocco, 1988; 
Tzivoni, 1989; Deedwania, 1990; Yeung, 1991) compared with 13-22% who had 
ischaemia and experienced similar end-points but were not selected on the basis of a 
positive exercise test (Mulcahy, 1992; Quyyumi, 1993). In this situation, the inclusion 
criterion of a low workload positive exercise test results in a spurious association of 
ambulatory ischaemia with adverse prognosis.
If results from studies of outpatients recruited from cardiology clinics are applied 
to the general population of patients with stable angina, then they should be 
representative of the broad spectrum of patients seen in clinical practice. If this were 
the case, then the rate of objective cardiac end-points such a myocardial infarction and 
cardiac death would be broadly similar among the different study populations. 
However the estimated annual rate of myocardial infarction and cardiac death varies 
by over four-fold in studies of stable angina patients (Tzivoni, 1989; Mulcahy, 1992) 
in spite of similar follow-up periods (Figure 1.3). The reported studies of ambulatory 
monitoring represent extremes of either ‘low’ (Mulcahy, 1992; Quyyumi, 1993) or 
‘high’ risk (Deedwania, 1990) groups.
The differences in outcome are, in part, explained by differences in clinical 
practice. For example in the study by Deedwania and Carbajal (1990), although 77 
patients had two or more coronary arteries diseased at baseline angiography, including 
13 patients who had left main stem disease, a total of only 2 patients underwent 
revascularisation at a mean follow-up period of 23 months. During this period 16 out 
of the total study population of 107 patients died, resulting in a total mortality of 15 %, 
and of 25% in those with episodes of ambulatory ischaemia. It is difficult and 
inappropriate to extrapolate conclusions from this study to patients seen in usual 
clinical practice because rate of revascularisation in patients with severe disease can 
be expected to be much higher and the mortality in stable angina patients lower
■  Hoi Positive H Hoi Negative
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Figure 1.2 Prevalence of ambulatory ischaemia in stable angina patients who 
experienced the end-points of myocardial infarction or death in prognostic studies 
of holter monitoring
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Figure 1.3 Variation in event rate for the combined end-points of myocardial 
infarction and death in studies assessing prognostic value of ambulatory ischaemia
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(Kannel, 1972). An unusually low rate of coronary intervention in angina patients 
with ambulatory ischaemia with the likelihood of the resultant higher mortality may 
exaggerate the prognostic value of ambulatory ischaemia.
A spurious association in the reverse direction can result when patient selection 
is biased towards a low-risk group. In a study which did not require the presence of 
exercise ischaemia for inclusion (Mulcahy, 1992), patients with an exercise test 
negative for ischaemia experienced almost twice as many myocardial infarctions or 
deaths compared with the positive exercise test group. In that study, the absence of 
ambulatory ischaemia was associated with a two-fold higher event-rate compared with 
patients who had transient ischaemic episodes (2.8% vs 7.0%). In that study, in 
which patients were selected non-consecutively from two different centres, only 2 of 
63 (3.2%) patients with both exercise and ambulatory ischaemia experienced a 
myocardial infarction or died compared with 5 of 59 (8.5 %) patients without evidence 
of ischaemia who sustained a myocardial infarction. The apparent prognostic benefit 
associated with the presence of ambulatory and exercise induced electrocardiographic 
ischaemia is at variance with previous reports which have shown reduced survival in 
patients with exercise induced ischaemia (ECSSG, 1982), and almost certainly reflects 
the arbitrary selection of a Tow risk’ patient population.
Finally, another important caveat of studies of ambulatory ST segment 
monitoring is the failure to demonstrate the independent contribution of ambulatory 
ischaemia to prognosis. The inclusion of varying proportions of patients with prior 
myocardial infarction - ranging from 0% (Tzivoni, 1989) to 52% (Deedwania, 1990) - 
confounds outcome because in patients with angina, a history of previous myocardial 
infarction is independently associated with reduced survival (Weiner, 1984). Thus 
spurious associations result because multivariate analysis to take account of important 
differences in baseline clinical characteristics between the comparison groups is not 
used (Tzivoni, 1989; Mulcahy, 1992).
1.5 Exercise Electrocardiography
Despite a large number of investigations including radionuclide scanning and 
echocardiography that are now available, the treadmill exercise test remains the most 
widely used for diagnostic and prognostic evaluation of patients with suspected 
coronary heart disease. Available evidence suggests however, that less than 10% of
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medically treated angina patients in the general population undergo exercise testing 
(Cannon, 1988).
Many studies report the frequency and prognostic implications of exercise 
induced ischaemia in patients with angina, but large differences in selection criteria 
and reported results make it inappropriate to draw any conclusions about exercise 
characteristics of angina patients in the general population. A meta-analysis of 150 
studies reported between 1966 and 1987 from 117 institutions involving 24,094 
patients (Detrano, 1989) shows that the sensitivity of an exercise test for > 5 0 %  
coronary artery stenosis ranges from 20% to over 90% (mean 68 +. 16%) with a 
similar range in specificity (mean 77 +. 15%). The authors used over 40 variables in 
both linear and logistic regression analysis but were able to explain less than 35 % of 
the variance. The major problem was inability to quantify bias from patient selection 
in the studies reviewed.
The influence of this bias on prevalence and prognostic implications of exercise 
induced ischaemia is illustrated by reports from the Coronary Artery Surgery Study 
(CASS), one of the largest prospective multicentre studies of patients with stable CHD 
(Killip, 1981). Data analysis in various reports from this study was based on a 
registry of 24,959 consecutive patients with suspected or proven coronary artery 
disease referred for cardiac catheterisation to 15 centres. Most patients usually 
undergo exercise testing prior to referral for catheterisation. This initial work-up bias 
(Philbrick, 1980) is not discussed in any of the reports on exercise testing from the 
CASS study, but the authors acknowledge the limitations of extrapolating results from 
a catheterised population to the wider spectrum of patients with angina (Weiner, 
1984).
The reported prevalence of exercise-induced ischaemic ST segment depression 
among patients drawn from the CASS registry ranges from 41% in medically treated 
men and women (Weiner, 1984) to 80% in men with definite angina (Weiner, 1979), 
and based on symptom category, from 30% to 79% in patients with non-ischaemic 
chest pain and definite angina respectively (Weiner, 1979). Among the four CASS 
reports, the proportion of male patients included in the studies varies from 72% 
(Weiner, 1979) to 90% (Ryan, 1985) and of patients with previous myocardial 
infarction from 0% (Weiner, 1979) to 60% (Ryan, 1985). Prevalence of angiographic 
coronary artery disease varies from 58% (Weiner, 1979) to 100% (Ryan, 1985).
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Although drawn from a single registry, patient selection results in wide variation of 
clinical characteristics. No single study represents the broad spectrum of patients with 
coronary heart disease encountered in clinical practice. Nevertheless conclusions from 
such studies are often erroneously interpreted as representative of the generality of 
patients with coronary heart disease.
The CASS reports conclude that exercise variables are helpful in assessing 
prognosis (Weiner, 1984) and in predicting improved survival following bypass 
surgery (Weiner, 1986). In both these observational studies from the CASS registry, 
multivariate analysis clearly shows a stronger independent association of a history of 
prior myocardial infarction with reduced survival than any of the exercise variables 
considered. The important confounding effect of prior myocardial infarction, the 
prevalence of which is significantly different between the comparison groups in one 
case (Weiner, 1986) and between survivors and non survivors in another (Weiner, 
1984), is ignored by the authors.
These observations underline two important limitations which affect much of the 
literature about electrocardiographic ischaemia and prognosis: (i) the failure to take 
account of a history of prior myocardial infarction which is a strong independent 
predictor of reduced survival, and (ii) the failure to consider the independent 
contribution of all baseline clinical variables which often leads to misleading 
conclusions about the relative importance of electrocardiographic variables for risk 
stratification or for predicting intervention related survival.
An additional aspect of study design and methodology which limits 
generalisability of results is the number of patients eventually selected from the pool 
of all eligible patients at outset. For example, of the four CASS reports cited, any one 
study included only 3% to 21 % of all patients on the registry. The randomised study 
included only 31% of all patients eligible for randomisation and ultimately consisted 
of only 3% of patients on the registry. Likewise in prospective studies assessing the 
prognostic implications of exercise induced ischaemia in mildly symptomatic patients 
with coronary artery disease (Bonow, 1984 and 1987) or in patients with recent onset 
angina undergoing cardiac catheterisation (Castener, 1990), the inclusion of a 
maximum of 131 patients over four years indicates a recruitment rate of about 32 
patients per year. Assuming a thousand patients per year undergo angiography for 
coronary heart disease at any given centre, as a conservative estimate this figure
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represents less than 5 % of all catheterised patients. Conclusions from such studies are 
therefore not applicable to all patients with angina in the clinical setting.
Although an exercise test is frequently used in the primary care setting for risk 
stratification of new patients in the general population presenting with chest pain, and 
for selecting patients for cardiac catheterisation, its prognostic value has not been 
validated in an unselected patient population.
1.6 Conclusion
Angina pectoris is prevalent in over one million men and women in the United 
Kingdom. It affects many daily living activities and results in absence from work. 
Patients presenting with angina pectoris in the general population have a threefold 
increased risk of developing unstable angina, myocardial infarction or death within two 
years of first presentation.
Despite the significant morbidity and mortality, there is surprisingly no 
contemporary data about the incidence and prognosis of angina pectoris in the general 
population. Studies of hospital patients are unrepresentative because even though a 
patient with angina consults a general practitioner two or three times a year, less than 
a fifth of patients treated by general practitioners are referred for hospital cardiological 
evaluation.
In patients with angina, electrocardiographic evidence of ischaemia has 
conventionally been regarded as an important indicator of subsequent prognosis. In 
particular, the ‘total ischaemic burden’, that is, ischaemic ST segment depression with 
and without anginal chest pain detected by continuous ambulatory electrocardiographic 
monitoring is thought to represent a more complete picture of ischaemic heart disease 
activity. Extensive investigation of ambulatory ischaemia in hospital outpatients with 
stable angina over the past two decades has, however, produced controversial results 
with a wide range in reported frequency (24% to 82%) and discrepant results about 
its prognostic value - ranging from an eleven-fold increased risk for myocardial 
infarction or death to a risk reduction of 70% for the same end points.
A study of men and women in the general population was initiated to quantify 
incidence of angina pectoris, to describe its natural history and outcome in the 
revascularisation era, and to assess the frequency and prognostic value of ambulatory 
ischaemia in the generality of unselected angina patients. The specific objectives of
this study and its design are outlined in the next section.
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1.7 Aims
1.7.1 To determine the frequency and clinical significance of ambulatory myocardial 
ischaemia in unselected men and women presenting for the first time with typical 
angina pectoris.
Secondary aims
1.7.2 To determine the clinical incidence and short-term prognosis of angina pectoris 
in the general population.
1.7.3 To investigate the prognostic value of an exercise test in patients presenting 
with angina pectoris in the general population.
1.7.4 To assess general practitioners’ perceptions of current investigation and 
management of angina pectoris.
1.8 Study Design
• survey of incident angina pectoris from a registered randomly selected general
practice population
• case-control comparison of the frequency and characteristics of ambulatory 
ischaemic changes in incident cases of angina with asymptomatic age, sex and 
practice matched healthy subjects
• prospective follow-up of patients to assess clinical outcome 
and a
• postal questionnaire survey of unselected general practitioners.
CHAPTER 2 
METHOD
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2.1 Area of Study
Southampton, a port 76 miles south-west of London, is part of the Wessex Regional 
Health Authority area which serves a total population of three million. The population 
of Southampton is 422,000 (OPCS 1989). Compared with the national average, the 
standardised mortality ratio for ischaemic heart disease in this region is 8% lower in 
men and 12% lower in women (OPCS, 1991).
2.2 Questionnaire Survey of General Practitioners
A postal questionnaire survey of all 217 general practitioners listed with the 
Hampshire Family Health Services Authority in the Southampton area was undertaken 
over a three month period to assess perceptions about the current investigation and 
management of angina pectoris; specifically about the value of exercise testing, 
coronary angioplasty and coronary artery bypass grafting, and to estimate the 
proportion of angina patients reportedly referred for a consultant opinion. All 
practices were in an area close to a regional cardiac centre in Southampton. To 
maximise response rates, a follow up questionnaire was posted after three weeks if no 
reply had been received. Confidentiality was maintained by number coding the 
questionnaires (Appendix 1).
The questions concerned the importance of symptom frequency and duration 
as a guide to disease severity, a ‘usefulness’ rating for different indications of exercise 
testing, confidence at correctly interpreting a resting and exercise electrocardiogram, 
knowledge about scientific evidence of benefits of revascularisation, and referral of 
patients with angina for hospital cardiological assessment.
2.3 Pilot Study
Four practices were recruited during an initial three month period to estimate referral 
rates and to finalise documentation including the questionnaire and examination forms.
2.4 Selection and Recruitment of General Practices
The 64 general practices in the Southampton area under the Hampshire Family Health 
Services Authority were stratified according to the number of partners per practice, 
and 25 had five or more partners. Using a Minim program for randomisation on an 
IBM PC50 computer, 17 of these practices were randomly selected in 3 stages
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between June and December 1990. Eight practices were recruited by August 1990, 
12 by October 1990 and 17 by December 1990.
Recruitment was undertaken by arranging a meeting with the general 
practitioners at the individual practices. The research objectives as well as the method 
of operation of the Chest Pain Clinic and the service to be provided were explained 
in detail in the presence of all practice partners. It was emphasised that because the 
incidence of angina was being measured, it was essential for all patients with suspected 
angina to be referred to the Clinic. General Practitioners were specifically asked to 
refer men and women up to the age of 70 years presenting for the first time with chest 
pain which in their opinion could be stable angina. This included any patient for 
whom a trial of antianginal therapy like sublingual nitrates would be prescribed, or 
who would be referred to a hospital physician for assessment. GPs were specifically 
advised not to refer patients with acute chest pain suspected to be unstable angina or 
evolving myocardial infarction who would be admitted directly to a coronary care unit 
in the usual way.
The partners and trainees in each of the 17 practices agreed by a consensus 
decision to participate in the study (Appendix 2). To maximise referral rates, a letter 
reminding each of the 117 participating partners and trainees of the need to refer all 
new patients with suspected angina to the Chest Pain Clinic was sent every month. 
Attached to this was an anonymous report of referral rates by individual practices, 
with the breakdown of patients referred by each partner within the practice.
2.5 The Study Population
2.5.1 Criteria for referral to clinic
a) Men and women up to and including 70 years of age registered with one of the 
participating general practitioners.
b) All patients presenting for the first time with chest pain which in their general 
practitioner’s opinion could be angina pectoris.
c) Patients prescribed a trial of sublingual nitrates.
d) Patients presenting with recurrent chest pain if previous episodes were not 
originally suspected to be coronary heart disease.
2.5.2 Exclusion criteria
a) Patients already on long term antianginal therapy for stable angina.
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b) Patients with any previous diagnosis of coronary heart disease, eg unstable angina 
or myocardial infarction.
c) Patients with known congenital or valvular heart disease or cardiomyopathy.
d) Patients presenting with acute chest pain thought to be unstable angina or 
myocardial infarction who in the opinion of the general practitioner required hospital 
admission.
2.5.3 Selection of controls
For every patient with typical angina (Section 2.9.1), up to two age, sex and practice- 
matched asymptomatic subjects were drawn at random from a computerised register 
of the study population and were invited to attend a screening examination (Appendix 
3). Individuals with a current or past history of coronary heart disease, or any of the 
above exclusion criteria were not studied.
2.6 Chest Pain Clinic
An open access Chest Pain Clinic was established at the Royal South Hants Hospital 
which is one of two teaching hospitals in Southampton and has 238 acute admission 
beds including a 9-bed coronary care unit. The regional cardiac centre for Wessex 
(population 3 million) is located at the Southampton General Hospital where the 
consultant cardiologists provide a predominantly tertiary referral service.
The Chest Pain Clinic was based in the department of Non Invasive 
Cardiology staffed by 3 full time cardiac technicians, 1 part time technician, 2 
cardiographers and a secretary. The investigative services for the hospital and district 
outpatient centre included resting, exercise and ambulatory electrocardiography, 
echocardiography and ambulatory blood pressure monitoring. This facility had three 
rooms; one used for clinical examination of patients, another for exercise testing and 
echocardiography, and a third room for administration.
The Chest Pain Clinic was run as an open access service to which patients 
were referred by their general practitioner without prior appointment between 9am and 
lpm Monday to Friday. When patients presented outside clinic hours, the GP referred 
them to the next available clinic. A referral form stating the patient’s name, address 
and current medication, and a chest X-ray request card was completed by the GP, and 
given to the patient to take to the clinic (Appendix 4). A map showing the location 
of the clinic within the hospital was provided.
33
2.7 Consent
The study was granted ethical approval by the regional Ethics Committee. Written 
informed consent for participation in the study and for the use of results for research 
purposes was obtained from all patients and controls (Appendix 5).
Each patient initially completed a questionnaire (Section 2.8). A chest X-ray 
and resting electrocardiogram (Section 2.11.1) were then obtained. After a full 
clinical examination, each patient was classified on the basis of the history detailed in 
Section 2.9. Further investigations including exercise and ambulatory 
electrocardiography (Section 2.11.2 and 2.11.3) were then undertaken in patients with 
angina pectoris.
2.8 Questionnaire (Appendix 6)
All patients and controls completed a self administered questionnaire which covered 
the following:
a) demographic data
b) past medical history
c) current medication
d) smoking history
e) history of alcohol ingestion
f) Rose chest pain questionnaire
g) for women, questions relation to gynaecological history and hormone 
replacement therapy.
2.9 Clinical Classification
A complete structured history of the presenting complaint including the site, character, 
precipitating and relieving factors was recorded together with the frequency and 
duration of symptoms. This was done blind to the questionnaire data and prior to the 
exercise test. On the basis of the history, each patient was assigned to one of the 
following categories:
2.9.1 Typical angina pectoris
Defined according to an anatomically (Weiner, 1979) and prognostically (Murabito, 
1990) validated definition as:
a) recurrent
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b) brief episodes of chest pain (up to 15 minutes)
c) precipitated by exertion or exertion and emotion
d) relieved by rest or nitroglycerin
e) character and radiation consistent with the diagnosis
2.9.2 Other categories
a) Possible angina:
When ‘c’ and any one or more (but not all) of the other characteristics listed in 2.9.1 
were present, the patient was classified as having possible angina.
b) ‘Atypical Pain ? Cause’:
This classification was used when the history was not consistent with typical or 
possible angina, but where the exact cause of pain was uncertain.
c) Non cardiac pain:
When the history and examination were totally inconsistent with the diagnosis of 
coronary heart disease or suggested an alternative cause of pain.
d) Unstable angina or myocardial infarction:
Patients with a history of rest pain suggestive of unstable angina or acute myocardial 
infarction with our without electrocardiographic changes were admitted directly from 
the clinic to the coronary care unit.
e) Exclusions:
Patients with any of the criteria listed in Section 2.5.2 were re-referred, as 
appropriate, to a medical outpatient clinic for assessment.
2.10 Clinical Examination
Each patient underwent a complete general and cardiovascular clinical examination. 
The findings were recorded on an examination form (Appendix 7) and included:
a) weight in kilogrammes
b) height in metres
c) heart rate and rhythm
d) signs of hyperlipidaemia
e) jugular venous pressure, position of cardiac apex, character of heart sounds,
presence of any murmurs, bruits and the presence or absence of peripheral pulses.
f) blood pressure (Korotkoff phase V) was measured at least ten minutes after the
patient was seated. If the systolic blood pressure was > 1 6 0  mmHg and/or diastolic
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blood pressure was > 95 mmHg, the reading was repeated after fifteen minutes rest. 
A third reading was obtained for patients who subsequently returned for an exercise 
test. The lowest reading obtained was used in the analysis.
2.11 Investigations
The management scheme for patients assessed at the chest pain clinic is outlined in 
Figure 2.1. Except where contraindicated, patients with typical angina underwent the 
following investigations: a venous blood sample to measure a random cholesterol and 
glucose level; both were analysed at the hospital’s biochemistry laboratory.
If indicated, echocardiography and doppler studies were carried out to exclude 
significant valvular heart disease. Spirometry was carried out to assess chronic 
airflow limitation.
2.11.1 Resting Electrocardiogram (ECG)
A standard 12-lead resting ECG was recorded at a paper speed of 25 mm/sec using a 
Hewlett Packard pagewriter, Model HP 4750A. When Q waves or T wave inversion 
were evident in the inferior leads, a further recording was obtained during inspiration. 
All ECGs were coded blind by independent observers on data entry forms using a 
modification of the Minnesota code (Rose, 1982) detailed in Appendix 8.
2.11.2 Exercise Electrocardiography
An exercise test was carried out at a median of 3 days (range 2-6 days) following the 
patient’s initial clinic assessment.
a) All tests were performed prior to prescription of regular antianginal 
medication. Sublingual nitrates were prescribed in the interim period. Beta blockers 
prescribed for hypertension were tailed off and stopped 24 - 48 hours prior to 
exercise.
b) A Marquette Electronics Inc. Microcomputer Augmented Cardiograph n/ST 
stress test system was used. Careful attention was paid to skin preparation for 
electrode attachment to obtain low impedance. In men the attachment sites were 
shaved, cleaned with an alcohol swab, and after drying, gently wiped with gauze. The 
12 standard electrocardiogram leads - limb, augmented and precordial chest leads (I, 
n , HI, aVR, aVL, aVF, and Vl-6) were used. Prior to commencing exercise, a 12- 
lead ECG was recorded with the patient supine, standing and following 
hyperventilation.
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c) A maximal symptom-limited exercise test was carried out according to the 
Bruce Protocol with three minute incremental stages (Table 2.1).
Stage Time Speed Elevation METS
1 3 1.7 10.0 4
2 3 2.5 12.0 7
3 3 3.4 14.0 10
4 3 4.2 16.0 13
5 3 5.0 18.0 17
6 3 5.5 20.0 20
7 3 6.0 22.0 23
Table 2.1. Stages of the Bruce Protocol (Bruce, 1971)
Blood pressure was recorded using a suitable sized cuff at rest and at three 
minute intervals throughout the test, at peak exercise and during recovery. A 12-lead 
ECG was recorded at similar time intervals and at the onset of any symptoms. Three 
leads (I,ID, V5) were continuously monitored during exercise and additional 
recordings were obtained during ectopic activity or arrhythmia. ECG recordings were 
obtained for ten minutes into the recovery period, or until any changes reverted to the 
pretest baseline.
d) Test end-points included the development of severe angina, dyspnoea, 
exhaustion, hypotension, complex ventricular arrhythmia, a hypertensive response 
defined as a systolic blood pressure greater than 230 mmHg or a diastolic pressure of 
more than 120 mmHg, horizontal or downsloping ST segment depression of >  4mm 
in one or more leads, or at the patient’s request. If a patient developed chest pain 
during the test, the time of onset and relief were recorded.
e) At the end of recovery, a final report consisting of median complexes saved 
during pre-exercise manoeuvres (with patient supine, standing, post-hyperventilation) 
during exercise and at peak exercise, and also at the time of maximum ST segment 
depression was obtained.
f) All exercise ECG recordings were analysed blind by an experienced 
independent observer with visual interpretation overriding computer analysis 
(Appendix 9). ST segment depression was coded according to a modified version of 
the Minnesota code for post-exercise records (Rose, 1982). In addition, the extent of
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maximum horizontal or downsloping ST segment depression 80 milliseconds after the 
J point in each set of leads was recorded. An ischaemic response was defined as 0.1 
mV or greater horizontal or downsloping ST segment depression relative to the PR 
segment measured at J +  80 milliseconds.
2.11.3 Ambulatory electrocardiographic monitoring
Continuous 24 hour two-channel ambulatory electrocardiographic recordings were 
obtained on magnetic tapes using Tracker recorders. The recorders had a frequency 
response range between 0.05-100 Hz, conforming to the American Heart Association’s 
standard for evaluation of the ST segment (Pipberger, 1975). Ambulatory monitoring 
was carried out prior to commencing regular antianginal medication. Sublingual 
nitrates were used if required. Two pairs of bipolar electrodes recorded (i) an anterior 
CM5 lead with the exploring electrode at the ‘V5’ position on the precordium, and the 
indifferent electrode over the manubrium, and (ii) a modified inferior lead with the 
exploring electrode over the left iliac fossa and the indifferent electrode to the right 
of the manubrium (Appendix 10). A small quantity of electrode gel was applied to 
the attachment sites and the skin was abraded with gauze to reduce impedance. 
Monitor leads were attached to pregelled electrodes (Medicotest a/s, Type T-00-S) and 
secured with adhesive tape leaving stress loops. A 0.1 mV calibration signal was 
recorded at the beginning of each tape followed by electrocardiogram recordings in 
the supine, standing, left and right lateral positions and after hyperventilation to ensure 
that the ST segment was not affected by postural changes. The time at the end of the 
manoeuvres was noted.
Patients were encouraged to continue their normal daily living activities and 
were provided with a diary to record any exertional activity. They were instructed to 
press the ‘event’ button on the recorder and to note the time of onset, duration and 
character of any chest discomfort during the recording period. A typewritten sheet 
stating the above instructions was also provided (Appendix 10).
All tapes were visually analysed in a blinded fashion at 60 times the normal 
speed on a Reynolds Pathfinder III analyzer which had software incorporated for ST 
segment analysis. After initialisation, the cassette was calibrated with the pre-recorded 
signal. A reference mark was placed on the isoelectric part of the PR segment, the 
ST1 marker was positioned at the J-point and the ST2 marker at 80 milliseconds after 
the J-point. Significant ST segment depression was defined as 1 mm or more
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horizontal or downsloping ST segment shift 80 milliseconds from the J-point lasting 
at least one minute. Two episodes were separated by the ST segment returning to 
baseline for at least one minute. Significant ST segment elevation was defined as an 
upward shift of the ST segment of > 1mm above the isoelectric line. ST segment 
elevation during sleeping hours was noted separately. The presence or absence of 
anginal symptoms during episodes of ST segment change was noted from the patient’s 
diary.
Areas of interest on the ambulatory electrocardiogram were printed out at 25 
mm/second. These included the beginning of the record to exclude postural ST 
segment shift, and immediately preceding the onset, at the onset, at maximum ST 
segment shift and at the termination of an episode of significant ST segment change. 
Regular printouts of the baseline were obtained throughout the 24 hour period, as were 
traces of any arrhythmic events. A printout of the 24 hour trend of ST segment 
change was obtained with normal and with expanded time axes. The total number and 
duration of episodes per 24 hours were recorded. For individual episodes, the heart 
rate before onset, at onset and at peak ST segment change was recorded, as was the 
maximal degree of ST segment change, duration of episode and association with any 
symptoms (Appendix 11). Changes in the T wave vector in isolation were not 
regarded as evidence for ischaemia.
2.12 Management
When clinical investigations were complete, a preliminary handwritten report to the 
general practitioner on a typed pro forma summarising clinical findings, exercise test 
results and recommended management was handed to the patient. A full typewritten 
summary was subsequently posted to the patient’s general practitioner.
Advice on dietary and lifestyle changes to modify cardiac risk factors including 
cigarette smoking and hypercholesterolaemia were provided together with explanatory 
leaflets.
Referral to the regional centre to consider cardiac catheterisation was advised 
when appropriate, but any such referral and follow-up was ultimately the responsibility 
of the general practitioner. The chest pain clinic was not situated on the same site as 
the regional cardiac centre. The decision to undertake coronary angiography and 
revascularisation was made independently by a cardiologist at the regional centre
unaware of the objectives of this study.
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2.13 Follow-up
Follow-up data was undertaken for all patients with typical angina. Deaths were 
ascertained through the patient’s general practitioner. A questionnaire requesting 
information about current medication, chest pain, attendance at an outpatient clinic and 
hospital admissions was posted to all remaining patients (Appendix 12). A copy of 
the questionnaire was posted after three weeks to the non-responders. Where possible, 
information from non-responders was obtained by telephone interview.
All questionnaire responses were corroborated with the patient’s hospital 
clinical records. A search of the registers in the cardiac catheterisation laboratories 
at the regional centre identified patients who had undergone coronary angiography. 
Copies of clinical summaries were obtained from records of all patients reviewed at 
the cardiac centre, and a note was made of any percutaneous transluminal coronary 
angioplasty or coronary artery bypass grafting procedures undertaken. Hospital 
records of patients admitted with chest pain were reviewed, and myocardial infarction 
documented by the admitting team based on the history and a two-fold rise in cardiac 
enzymes and/or characteristic electrocardiographic changes was recorded.
2.14 Statistical Analysis
2.14.1 Incidence
Incidence rates per thousand per year with 95 % confidence intervals were calculated 
for the total population aged 31-70 years and for age and sex specific sub groups. 
These were calculated as the number of cases of typical angina divided by the number 
of person-years at risk during the study period x 1000. The age and sex distribution 
of the population at risk was obtained from the registers of the participating general 
practices. Age and sex specific incidence rates were applied to the 1991 United 
Kingdom population projections to estimate the number of new angina cases per year 
(OPCS, 1993). Clinical outcome was assessed in relation to the first of the following 
events: death, myocardial infarction, percutaneous transluminal coronary angioplasty, 
and coronary artery bypass grafting. A survival curve was constructed using the 
Kaplan-Meier technique to demonstrate the cumulative probability of event-free 
survival during the follow-up period.
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2.14.2 Ambulatory and exercise ischaemia
Normally distributed data was summarised by mean and standard deviation and skewed 
data by a median and range. Comparisons between subgroups were made using a x2 
test (without continuity correction) for categorical data and a t-test for continuous data. 
The Mann-Whitney U-test was used for comparison of non-normally distributed data 
between subgroups. Logistic regression analysis was used separately in men and 
women to determine the independent association of clinical characteristics and exercise 
parameters with ambulatory ischemic activity. A stepwise procedure was used to build 
the model using a cutoff of p = 0.05 to determine entry. Clinical variables entered first 
in the analysis were frequency and duration of symptoms, age, sex, systolic and 
diastolic blood pressure, current cigarette smoking, and serum cholesterol. Exercise 
variables then added were presence of ischemia (ST segment depression >  1mm), 
peak rate pressure product and total exercise duration. Statistical significance was 
tested using the likelihood ratio statistic. Survival curves were constructed using the 
Kaplan-Meier technique to examine the cumulative probability of an adverse event 
(death, myocardial infarction, percutaneous transluminal coronary angioplasty or 
coronary artery bypass grafting) in those with and without ambulatory ischemia, and 
compared by the log-rank method (Armitage, 1987). All analyses were performed 
using Statistical Analysis System, version 6 (SAS Institute Inc, Cary, NC.).
The analysis between exercise variables and outcome was performed in a 
similar way using Kaplan-Meier survival curves. Patients were stratified according 
to the presence or absence of > 1mm exercise ST segment depression and also 
according to a total exercise duration of < or > 6 minutes. Data was explored for 
interaction due to gender. A Cox proportional hazards regression model including 
age, sex, serum cholesterol, current smoking habit, hypertension, symptom frequency 
> once daily, duration of symptoms < 1 month, peak rate pressure product and the 
presence of exercise ischaemia were included to assess the independent contribution 
of baseline clinical characteristics and exercise variables to subsequent prognosis. 
Separate analyses were carried out with and without revascularisation procedures as 
end-points in addition to death and myocardial infarction.
CHAPTER 3
GENERAL PRACTICE QUESTIONNAIRE SURVEY
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3.1 Introduction
The management of angina has altered radically over the last two decades. In the past 
a prescription of sublingual nitrates sufficed (Fry, 1976), but with the advent of 
revascularization and its benefits in relieving symptoms (Parisi, 1992), improving 
quality of life (CASS, 1983) and prolonging survival (Vamauskas, 1988) in selected 
patients, the onus is now on general practitioners to choose patients with angina for 
cardiological evaluation with a view to coronary angioplasty or bypass surgery.
Whether or not management of angina in general practice has altered to reflect 
advances in cardiological management is uncertain. The aim of this questionnaire 
survey was to assess general practitioner opinion about the investigation and treatment 
of angina. Specifically, the objective was to estimate the proportion of patients who 
are reportedly referred for a Consultant opinion, and to assess general practitioners’ 
perceptions about the value of exercise testing, coronary angioplasty and coronary 
artery bypass grafting.
The method of this questionnaire survey is outlined in Section 2.2.
3.2 Results
A total of 171 general practitioners returned the questionnaire giving a response rate 
of 79%.
Figure 3.1 shows the importance attached to the frequency and duration of 
angina in assessing severity of underlying coronary artery disease. About half of the 
general practitioners considered frequency of angina to be a reliable guide to disease 
severity, but an equal number did not. Their views differed similarly in relation to 
the duration of angina prior to presentation.
In patients with suspected cardiac symptoms, general practitioners commonly 
perform a resting electrocardiogram. Their reported confidence at correctly 
interpreting it for signs of ischaemia and infarction varied with three quarters stating 
they were usually or almost always confident, but a quarter stating that they were only 
sometimes (19%) or almost never (6%) confident (Figure 3.2). By contrast the 
majority were almost never (56%) or only sometimes (24%) confident at correctly 
interpreting an exercise test.
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3.2.1 Exercise testing
The ‘usefulness rating’ of an exercise test for making a correct diagnosis and for 
assessing prognosis is shown in Figure 3.3. The majority thought an exercise test was 
useful in making a diagnosis but only half considered it useful for assessing prognosis 
in patients with angina. In assessing other indications for exercise testing, the 
percentage of general practitioners who gave ratings of ‘frequently or almost always 
useful’ varied from 8% for screening asymptomatic patients, 45% for reassurance, and 
78% for selecting patients for coronary angiography.
3.2.2 Revascularisation
The majority of general practitioners agreed there was scientific evidence for benefit 
from coronary angioplasty in relieving symptoms (Figure 3.4), and 71% thought this 
applied to all age groups. In addition, a fifth were of the opinion that prolongation 
of survival with coronary angioplasty has also been demonstrated, but 40% were 
unaware of what the current evidence was in relation to angioplasty and survival.
Almost all (96%) were satisfied that coronary artery bypass surgery relieved 
symptoms and the majority (70%) considered this to be the case for all age groups. 
But there was more uncertainty about improved survival with bypass surgery and 38% 
either didn’t know, or thought there was no evidence for this (Figure 3.4). Among 
those who thought bypass surgery prolongs survival, 44% thought this applied to all 
age groups but about a third (32%) considered the evidence applied to the under 65 
year age group only.
3.2.3 Hospital investigation
In deciding whether or not to refer patients presenting with angina for cardiological 
assessment, frequency and duration of symptoms were considered important by 93% 
and by 78% respectively. While age was considered very important by 68%, gender 
was of little or no importance to 72% of general practitioners when deciding to refer 
a patient to a cardiologist.
Figure 3.5 shows reported estimates of the proportion of patients with stable 
angina referred for investigation. Seventy-two percent of general practitioners report 
referral of only a quarter of all their patients with stable angina to a hospital physician. 
Fewer patients are referred directly to a cardiologist at the regional centre, with 80% 
referring a maximum of only 10% of patients.
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When they do refer a patient with angina to an outpatient clinic for an exercise 
test, 46% of general practitioners report a period of three months or longer before the 
results and management plan become available.
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Figure 3.1 General Practitioners’ responses to the question ‘In a patient with 
stable angina do you consider symptom characteristics in terms of frequency and 
duration a reliable guide to the severity of underlying coronary artery disease?’ 
(n = 171 respondents)
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Figure 3.2 General Practitioners’ reported confidence in correctly interpreting 
a resting and exercise electrocardiogram (n = 169 respondents).
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Figure 3.3 Ratings given by General Practitioners for the ‘usefulness’ of an 
exercise test for diagnosis and for assessing prognosis in patients with angina (n 
= 171 respondents).
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symptoms survival symptoms survival
PTCA CABG
Figure 3.4 Responses to questions about revascularisation:4In your opinion, for
patients with stable angina, is there scientific evidence to show that percutaneous 
transluminal coronary angioplasty (PTCA) and coronary artery bypass grafting 
(CABG) a) relieve symptoms and b) prolong survival?’ (n = 171 respondents)
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Figure 3.5 ‘What proportion of your stable angina patients are referred a) to 
a general hospital physician b) directly to a cardiologist at the regional centre?’ 
(n = 171 respondents)
CHAPTER 4
PATIENT CHARACTERISTICS AND CHEST PAIN CLINIC
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4.1 Patients referred
The open access Chest Pain Clinic was set up solely for the purposes of this study. 
A total of 489 patients were referred to this clinic between June 1990 and March 
1992. At all ages, there were more male than female patients. Twenty-two patients 
did not meet the criteria for eligibility for clinic referral. Of these, 12 were aged 71 
years or over, 7 patients had a past history of coronary heart disease, and 3 patients 
were referred from outside the registered study population.
One hundred and ten consecutive patients who presented with typical angina 
pectoris (section 2.9.1) were included in the study. Sixty-three per cent (n=70) were 
male, and 37% (n=40) were female.
The remainder of referrals were classified as follows (section 2.9): n=63 
(13%) with possible angina; n=63(13%) with ‘atypical pain ? cause’; n=204 (44%) 
with non-cardiac pain, and 27 (6%) patients were admitted to the coronary care unit 
because the history and/or electrocardiogram was consistent with unstable angina or 
myocardial infarction.
4.2 Demography
The age and sex structure of 110 patients with typical angina is shown in Figure 4.1 
The majority (92%) of the patients had lived in the area of study for over 10 years, 
representing a stable study population (Figure 4.2).
The social class distribution in Figure 4.3 shows that the vast majority of 
patients presenting with angina belonged to the manual or non-manual skilled 
occupations.
4.3 Symptom Characteristics
The duration of angina symptoms reported prior to initial assessment at the Chest Pain 
Clinic was variable (Figure 4.4). Although the majority of patients were assessed 
within 24 hours of their general practitioner first suspecting a diagnosis of coronary 
heart disease, 61 % of patients reported experiencing angina for longer than one month 
prior to the clinic visit. Ten per cent reported the presence of symptoms for more 
than one year.
The majority reported experiencing anginal pain daily or up to two or three 
times a week. (Figure 4.5).
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4.4 Cardiac Risk Factors
4.4.1 Hypertension
Hypertension was defined as a systolic blood pressure of >160 mmHg and/or a 
diastolic blood pressure of > 100 mmHg on at least two recordings, or when the 
patient was receiving antihypertensive medication. A higher cut-off for diastolic blood 
pressure was used to allow for clinic readings.
Prevalence of hypertension in patients with angina (Figure 4.6) was 48% (53 
of 110). In the 53 patients with hypertension, raised blood pressure had been 
previously undetected in 26%, detected but not treated in 34%, and inadequately 
treated in 17%.
4.4.2 Hypercholesterolaemia
The distribution of random serum cholesterol measurements is shown in Figure 4.7. 
Total serum cholesterol level was >  6.5 mmol/L in 75% of patients with typical 
angina, and > 9 mmol/L in 12% of these patients. There was no significant 
difference in the proportion of patients with a family history of coronary heart disease 
among those with a cholesterol level > 6.5 mmol/L compared with a level < 6.5 
mmol/L (53% vs 38%, p = 0.15). In all but one patient, hypercholesterolaemia had 
been previously unrecognised.
4.4.3 Smoking, diabetes, and obesity
The prevalence of current cigarette smokers among patients with typical angina was 
30%. A further 38% were ex-smokers, 23% lifelong non smokers and 9% pipe or
cigar smokers. Ex-smokers had given up smoking for at least one year.
Obesity, defined as a body mass index > 30 kg/m2, was prevalent in 27%
(30 of 110) of patients with typical angina.
A random plasma glucose level > 1 1  mmol/L was detected in two patients 
with angina who were not known diabetics. A further 7 (6%) patients had previously 
diagnosed diabetes mellitus.
The proportion of patients presenting with typical angina in the general 
population who had major cardiovascular risk factors was high: 82% of patients had 
one risk factor, and almost a third (32%) had two major cardiovascular risk factors.
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4.5 Clinic Workload
Over 95 % of patients were assessed at the clinic within 24 hours of referral by the 
general practitioner. Patients seen at the weekend were referred to the next available 
clinic.
The mean referral rate was 28 patients per month. The overall referral rate 
to the Chest Pain Clinic was 193 patients per 100,000 population under 70 years of 
age per year.
A total of 317 patients assessed at the clinic during the 1991 calender year 
contributed to 4.4% of the department’s resting electrocardiography workload. 
Twenty-three per cent (139 of 595) of exercise tests carried out in the department 
during 1991 were generated by the chest pain clinic.
A full typewritten summary stating clinical findings, investigation results, 
diagnosis and recommended management was posted to the general practitioner within 
7 days in 72% of cases, and within two weeks of referral in 90% of cases (Figure 
4.8). Management recommendations to the general practitioner included advice about 
risk factor modification and medical therapy.
55
Figure 4.1
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Figure 4.2 Number of years resident in area of study.
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Figure 4.3 Social class distribution of patients with typical angina pectoris.
(I= professionals; 11=intermediate occupations; IIIN= skilled occupations - non-manual; HIM= skilled 
occupations - manual; IV=partly skilled occupations; V = unskilled occupations; unclassified= occupation 
not stated)
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Figure 4.4 Duration of typical angina symptoms reported by 110 patients prior
to clinic visit.
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Figure 4.5 Symptom frequency in patients presenting with typical angina.
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Figure 4.6 Hypertension in 110 new patients with angina pectoris.
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Figure 4.7 Distribution of random serum cholesterol in patients presenting with
angina pectoris in the general population.
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Figure 4.8 Time to general practitioner letter.
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CHAPTER 5
INCIDENCE AND SHORT TERM PROGNOSIS OF ANGINA PECTORIS
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5.1 Introduction
Little is known about the incidence or natural history of angina pectoris in the general 
population. The Framingham Study which commenced in 1949 was unique in 
recording incidence of angina in both men and women in the general population 
(Kannel, 1972) but its data is now outdated since a better understanding of 
cardiovascular risk factors, the availability of modem pharmacological agents, and the 
development of technology for coronary intervention procedures has coincided with 
a concomitant decline in both incidence and mortality of cardiovascular diseases 
(Sytkowski, 1990).
One of the aims of this study was therefore to estimate the clinical incidence 
of angina pectoris and to investigate the outcome of this disease following diagnosis.
5.2 Incidence
One hundred and ten consecutive patients presenting for the first time with typical 
angina were identified between June 1990 and March 1992 from a total registered 
population of 191,677. Of these 70 were male and 40 were female. The mean age 
was 57.4 (SD 9.6) years, range 34-70 years. Ninety-two per cent of the patients had 
been resident in the area of study for over 10 years.
Age and sex specific incidence rates for typical angina (Figure 5.1) were 
derived from the known age and sex structure of the study population (Appendix 2b). 
The crude annual incidence (95% confidence interval) in men and women aged 31-70 
years was 1.13 (0.85, 1.40) and 0.53 (0.33, 0.72) per thousand population per year 
respectively. The overall crude annual incidence of typical angina was 0.83 (0.66, 
1.0) per thousand patients aged 31-70 years per year.
The age and sex structure of the randomly selected study population was 
almost identical to the United Kingdom population (Figure 5.2). Applying these rates 
to the United Kingdom population gives an estimate of 22,570 (95 % Cl 17840, 27030) 
new patients presenting to their general practitioner with typical angina each year in 
the UK (Table 5.1).
As treadmill exercise testing was carried out on all patients with typical 
angina who did not have contraindications, separate estimates were derived for 
incidence of patients with angina and an ischaemic exercise test response. Of the 103 
patients who underwent exercise testing, 63 (61%) had an ischaemic response with
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> 1mm horizontal or downsloping ST segment depression. In the United Kingdom, 
the annual incidence of new patients with typical angina pectoris and exercise induced 
ischaemic ST segment depression is estimated at 9,370 (95% Cl 7,760, 11,450) men 
and 4,250 (95% Cl 2,890, 5,330) women.
5.3 Outcome
The median duration of follow-up was 15.8 months (range 7-30 months). Complete 
data was available for 107 of 110 (97%) patients with typical angina. The 3 patients 
lost to follow-up had moved without a forwarding address.
Table 5.2 shows outcome and Figure 5.3 the cumulative survival for the total 
cohort of patients with typical angina. Eleven per cent of patients presenting with 
angina died (n=4) or experienced non-fatal myocardial infarction (n=8) and 18% 
(n=20) underwent revascularisation. One of the deaths occurred in a patient with a 
low workload positive exercise test who also had co-existing prostatic malignancy. 
There were no special arrangements with the regional cardiac centre for assessment 
of patients included in the study and the decision for elective revascularisation was 
made independently by the cardiologists concerned based on their usual clinical 
practice.
Figure 5.4 shows the outcome among the 75 surviving patients who had not 
undergone revascularisation or experienced a non-fatal myocardial infarction at the 
time of follow-up. Angina resolved spontaneously in 12 (11%) patients, and with 
medical therapy in a further 21 (19%). About a third (32%) reported continuing 
symptoms in spite of medication and a further 4 patients were awaiting elective 
revascularisation.
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Age (years) Male Female
Up to 40 1,580 240
41-50 2,360 1,760
51-60 4,370 2,570
61-70 6,940 2.750
Total 15,250 7,320
95% confidence interval* (11,310, 18,630) (4,530, 9,880)
* derived from crude incidence rates
Table 5.1 Estimated number of patients presenting annually in the United 
Kingdom with typical angina pectoris.
OUTCOME
Male Female Months to 
(n = 70) (n = 40) event (median)
Death (n) 4 0 2.6
Myocardial 6 2 1.6
infarction (n)
PTCA* (n) 9 3 2.9
CABGt (n) 8 0 7.5
* excluding n =  1 female patient on waiting list 
t  excluding n = l female and n=2 male patients on waiting list 
PTCA =  percutaneous transluminal coronary angioplasty 
CABG =  coronary artery bypass grafting
Total Events 
(* )
3.6
7.3
10.9
7.3
Table 5.2 Outcome of 110 patients presenting with angina pectoris in the 
general population.
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Figure 5.1 Annual age and sex specific incidence of angina pectoris.
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Figure 5.3 Event-free survival of patients with angina pectoris at a median of 
15.8 months after first presentation (events = PTCA, CABG, myocardial 
infarction, death).
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Rx = on antfanginal medication
Figure 5.4 Outcome at a median of 15.8 months in n=75 angina patients who 
did not experience events listed in Table 5.2.
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CHAPTER 6
EXERCISE TEST CHARACTERISTICS AND PROGNOSTIC VALUE
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6.1 Introduction
An exercise test is used routinely in clinical practice to evaluate patients who present 
with exertional chest discomfort. Its diagnostic value is greatest in patients with 
atypical chest discomfort but, in those with typical angina, especially men in whom 
there is a high pre-test likelihood of disease, a positive exercise test contributes little 
additional diagnostic information (Detry, 1977; Patterson, 1984). In such patients the 
main reason for performing an exercise test is for prognostic risk stratification.
Some prognostic scores based on the treadmill exercise test suggest that 
exercise induced ST segment depression and total exercise duration may contribute to 
predicting survival in patients with angina (Mark, 1991; Morrow, 1993), but this 
finding is not consistent and in other studies exercise ischaemia was shown to be of 
no prognostic value (Duback, 1988).
The inconsistency in prognostic importance of exercise variables can be 
largely attributed to ‘work up bias’ (Philbrick, 1980). In a cohort of male veterans 
selected for coronary angiography, exercise induced ST segment depression was 
independently associated with reduced survival, but in patients referred to the same 
institution who were not selected for cardiac catheterisation, exercise ischaemia had 
no prognostic value (Brown, 1992). Patient selection criteria have a strong influence 
on whether or not an exercise variable will be of prognostic importance. Patients 
included in prognostic studies are often highly selected and misrepresent the intended 
population (Philbrick, 1982).
In spite of the widespread use of exercise testing for risk stratification, the 
prognostic value of total exercise workload and exercise induced ischaemia has not 
been validated in the generality of patients presenting with angina pectoris.
One of the secondary objectives of this study was therefore to describe the 
exercise characteristics of a representative sample of new patients with angina pectoris 
and to investigate the prognostic value of exercise test variables in such patients. In 
order to compare exercise characteristics, the normal response to exercise was 
evaluated in a broad spectrum of population based healthy men and women who were 
randomly selected from general practice registers (section 2.5.3).
The exercise protocol and the method of follow-up is described in sections
2.11.2 and 2.13 respectively.
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6.2 Patients
Of 110 patients with typical angina, 7 were excluded for the following reasons: n = l 
permanent pacemaker, n = l left bundle branch block, n = l  intermittent claudication, 
n=2 hospital admission prior to exercise test, n = l on digoxin and n = l because of 
an abnormal chest x-ray.
Of the 103 consecutive patients with typical angina who were prospectively 
enroled, 66 (64%) patients were male and 37 (36%) female. Mean age of the study 
population was 57.9 (SD 9.8) years.
6.3 Controls
Selection of controls is described in section 2.5.3. Of 110 eligible asymptomatic 
healthy controls, 107 did not have contraindications to exercise testing. There were 
65 men with a mean (SD) age of 56.3 (9.9) years and 42 women, mean age 57.7 (8.3) 
years. No subject had a current or past history of coronary heart disease, was taking 
beta blockers, or developed arrhythmia during the test.
6.4 Exercise Characteristics of Angina Patients
Ischaemic ST segment depression, defined as >  0.1 mmol horizontal/downsloping ST 
shift from baseline at J+80 m secs, was induced in 42 of 66 (64%) men and in 21 of 
37 (57%) women with angina. Marked exercise induced ischaemia, that is > 3mm 
ST segment depression, was prevalent in 29% of angina patients (20 male, 10 female). 
Mean (SD) exercise duration of patients with >  3mm ST segment depression was 5.9 
(2.2) minutes. Silent ischaemia was prevalent in only 11 of 103 (11%) patients.
Peak rate pressure product was equally and significantly reduced in those with 
and without ischaemia (Figure 6.1).
Total exercise duration or workload attained was also significantly reduced 
in patients with (6.5 min vs 9.8 min in controls) and without (7.0 mins vs 10.4 mins 
in controls) ischaemia; this difference was found in both men and women (Figure 6.2). 
The mean exercise duration on the Bruce protocol in men with angina was 7.0 (2.8) 
minutes compared with 11.0 (2.9) minutes in healthy male controls, and in women 
with angina it was 6.3 (2.4) minutes compared with 9.0 (2.1) minutes in female 
controls; p < 0.001 for both sexes.
A multivariate analysis including all baseline clinical characteristics was
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carried out to determine whether frequency and duration of angina could predict a low 
workload positive exercise test. Only systolic blood pressure was weakly associated 
with a low workload positive exercise test (OR 1.03, 95% Cl 1.0, 1.05).
6.5 Total Exercise Workload, Exercise Ischaemia, and Prognosis
6.5.1 Clinical characteristics
The 103 patients with angina pectoris who underwent an exercise test were divided 
into two groups according to final exercise stage reached: Group 1 consisted of n=43 
patients whose total exercise duration was <  6 minutes ie a maximum exercise 
workload of <  7 METS on the Bruce protocol, and Group 2 consisting of n=60 
patients who were able to exercise for >  6 minutes on the Bruce protocol.
Table 6.1 compares the baseline clinical characteristics of Group 1 and Group 
2 patients. Patients in Group 1 were older, had a higher mean serum cholesterol, 
more frequent angina and a lower peak rate pressure product compared with Group 
2. All remaining clinical characteristics including the proportion of male patients and 
mean body mass index were similar between the two groups.
6.5.2 Survival curves
During 15.8 months of follow-up (range 7-30 months), there were 4 deaths (one non- 
cardiac), 6 myocardial infarctions, 11 coronary angioplasty and 8 coronary artery 
bypass graft procedures. Of the 42 patients in Group 1 who did not exceed Stage 
n  of the Bruce protocol exercise test (<  7 METS), 21 (50%) experienced one of these 
end-points (Table 6.2). By comparison there were only 8 (14%) events in Group 2 
patients who reached Stage III or more of the exercise test.
Kaplan-Meier actuarial analysis of cumulative survival for both total events 
and separately for the combined end-points of non-fatal myocardial infarction and 
death revealed significantly reduced survival in patients with a lower exercise capacity 
(Figures 6.3 and 6.4). Total event-free survival in Group 1 was 50% compared with 
86% in Group 2 (log rank p < 0.0001), and survival free from non-fatal myocardial 
infarction or death was 83% in Group 1 vs 95% in Group 2 (log rank p < 0.05).
The effect of exercise induced ST segment depression on the clinical end­
points of myocardial infarction and death was evaluated in a separate analysis. There 
was no significant difference in survival free from myocardial infarction and death 
between patients with and without inducible ischaemia (Figure 6.5). This difference 
remained non significant even after women were excluded from the analysis.
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Total Exercise Duration
Group 1 Group 2
< 6 min > 6 min
mean Age (yr) 60.8 (7.5) 54.9 (10.5)*
male (%) 63 65
cigarette smokers (%) 21 37
hypertension (%) 53 47
serum cholesterol mmol/L 7.6 (1.4) 7.0 (1.2)t
diabetes 9% 7 8
body mass index (kg/m2) 28.8 (4.2) 27.4 (3.3)
Symptoms
frequency >  once daily (%) 47 25 f
duration <  one month (%) 40 45
Exercise
STD > 1mm (%) 70 55
rate pressure product (x 103)) 26.6 (5.9) 29.2 (5.7)t
value in parentheses is standard deviation 
STD =  ST segment depression 
* p < 0 .0 1  f  p <0.05
Table 6.1 Baseline clinical characteristics of n=43 patients with angina who 
completed 6 minutes (Group 1) compared with n=60 patients who completed 
> 6 minutes (Group 2) on the Bruce protocol treadmill exercise test.
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6.5.3 Multivariate analysis
A multivariate Cox’s hazard function analysis was carried out to assess the 
independent contribution of clinical and exercise variables listed in Table 6.1 to 
prognosis. Decreasing age, male gender and a total exercise duration less than six 
minutes emerged as the only independent predictors of reduced event-free survival 
(Table 6.3). Exercise induced ischaemia was not associated with reduced survival.
Because interventions such as PTCA and CABG which are censored in the 
survival analysis may be linked to a reduced exercise workload, the cox proportional 
hazards analysis was repeated to assess the relationship between baseline clinical 
characteristics and outcome with only non-fatal myocardial infarction and death as 
end-points. Total exercise duration <  6 minutes remained an independent predictor 
of adverse outcome (Relative Risk 3.6 95% Cl 0.9, 13.9), but exercise induced ST 
segment depression made no significant contribution to predicting myocardial 
infarction or death.
The positive predictive value of an exercise workload <  7 METS for clinical 
events, that is, the proportion of angina patients whose total exercise duration was 6 
minutes or less on the Bruce protocol and who experienced a clinical event during 
follow-up, was 50%. Combining the presence of exercise induced ST segment 
depression >  1mm with exercise capacity <  7 METS increased the positive 
predictive value for all endpoints from 50% to only 53%, and the specificity from 
70% to 80%, but reduced sensitivity for predicting adverse events from 72% to 55%.
6.6 Exercise Capacity in Asymptomatic Controls
Variables measured during the Bruce protocol treadmill exercise test among 
asymptomatic control subjects were plotted against age, separately for men and 
women, to determine any correlations.
A statistically significant correlation was found among both sexes between age 
and peak systolic blood pressure (Figure 6.6). For both men and women, significant 
inverse correlations were found between peak heart rate and total exercise duration 
(Figures 6.7 and 6.8). These were independent of body mass index, and in each case, 
the relationship was stronger in men.
Regression equations for the exercise variables as a function of age were 
derived for both sexes (Table 6.4).
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Group 1 Group 2
Death (n) 3 1
Myocardial infarction (n) 4 2
PTCA (n) 8 3
CABG (n) 6 2
Table 6.2 Clinical outcome in n= 58 patients who did (Group 2) and n=42
patients who did not (Group 1) exceed Stage n  of the Bruce protocol exercise test.
Relative Risk
(95% Cl) p value
Decreasing age * 1.1 (1.0, 1.1)* 0.03
Male gender 4.3 (1.5, 12.5) 0.008
Exercise duration < 6 min (<  7 METs) 8.3 (3.0, 23.1) 0.0001
* For each year of decreasing age.
Table 6.3 Multivariate analysis showing the independent association of baseline
clinical characteristics with outcome: relative risks for PTCA, CABG, non-fatal 
myocardial infarction or death.
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Men Women
Exercise Duration 
(minutes)
19.13 -(0.14 x age) 15.53 -(0.113 x age)
Peak Heart Rate 
(beats per min)
234.8 -(1.13 x age) 202.9 -(0.619 x age)
Peak Systolic Blood Pressure 
(mmHg)
143.6 +(0.91 x age) 121.4 +(0.978 x age)
Table 6.4 Regression equations for exercise variables as a function of age in 
asymptomatic healthy subjects performing the Bruce protocol treadmill test.
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Figure 6.1 Reduced peak exercise rate pressure product (x 103) in angina 
patients with (28.2 vs 30.9 in controls, p <0.05) and without (28.1 vs 32.5 in 
controls, p <0.001) ischaemia.
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Figure 6.3 Survival free from PTCA, CABG, MI and death according to 
exercise workload attained (50% in Group 1 vs 86% in Group 2, log rank
p <0.0001).
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Figure 6.4 Survival free from myocardial infarction and death according to 
exercise workload attained (83% in Group 1 vs 95% in Group 2, log rank 
p < 0.05)
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Figure 6.5 Event-free survival from non-fatal myocardial infarction and death 
in 62 angina patients with and 38 patients without inducible ischaemia (88% vs 
92% respectively, log rank p = 0.6).
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CHAPTER 7 
AMBULATORY MYOCARDIAL ISCHAEMIA
86
7.1 Introduction
Transient episodes of ischaemic ST segment depression detected by continuous 
ambulatory electrocardiographic monitoring have been extensively investigated, but 
the true frequency and clinical importance of ambulatory ischaemia in patients with 
stable coronary heart disease remains controversial. In selected hospital patients with 
positive exercise tests and angiographic coronary artery disease, some studies reported 
the majority of patients with angina to have ambulatory silent ischaemia (Cecchi, 
1983; Shea, 1985), but others found this not to be the case (Mulcahy, 1988). The 
proportion of patients with stable angina in whom ambulatory ischaemia is detected 
ranges from under 25% (von Amim, 1985; Thadani, 1992) to over 80% (Cecchi, 
1983). Gender differences in ischaemic activity have been poorly defined, and apart 
from smoking (Barry, 1989), the effect of cardiovascular risk factors is unclear.
There are conflicting reports about the prognostic importance of ambulatory 
ischaemia in patients with stable coronary heart disease. In selected patients with 
stable angina, ischaemic episodes detected by ambulatory monitoring were previously 
reported to be associated with a higher risk of subsequent fatal and non-fatal cardiac 
events (Rocco, 1988; Tzivoni, 1989; Deedwania, 1990), but more recent studies 
suggest the reverse is true with a higher rate of myocardial infarction or cardiac death 
in patients with no ischaemia on ambulatory monitoring compared to those with 
ischaemic changes (Mulcahy, 1992; Quyyumi, 1993).
These differences in prevalence of ambulatory ischaemia and its prognostic 
significance may be due to careful patient selection which results in arbitrary ‘low’ and 
‘high’ risk study groups unrepresentative of the broad spectrum of angina patients seen 
by most cardiologists - the ‘sickest of the sick and the wellest of the well’ (Diamond, 
1986). A striking four-fold difference in the annual rate of myocardial infarction or 
death between two studies which employed different patient selection criteria supports 
this view (Tzivoni, 1989; Mulcahy, 1992). Results from studies which select patients 
with longstanding angina (Mulcahy, 1992), low workload exercise tests (Rocco, 1988; 
Tzivoni, 1989; Deedwania, 1990; Yeung, 1991), and which include non consecutive 
referrals (Tzivoni, 1989; Mulcahy, 1992; Yeung, 1991) cannot be extrapolated to the 
generality of patients with angina pectoris. A physician needs to know the significance 
of ambulatory myocardial ischaemia in the type of patient with angina pectoris who 
presents in clinical practice. If ischaemia during daily activities at the time of initial
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presentation and work up is frequent, and if its presence can predict subsequent 
coronary events, then ambulatory monitoring would be valuable in risk stratification 
of new patients with angina.
A primary objective of this study was therefore to prospectively determine the 
frequency and prognostic significance of ambulatory myocardial ischaemia, and its 
relationship to cardiovascular risk factors, in previously untreated patients presenting 
for the first time with typical angina pectoris. Because the aim was to study a 
representative sample of patients with typical angina drawn from the general 
population, the demonstration of a positive exercise test or angiographic coronary 
artery disease was not a prerequisite. Prevalence of ambulatory ischaemia is described 
relative to the frequency of ischaemic ST segment changes in age and sex matched 
asymptomatic individuals drawn at random from the same population.
The method of ambulatory electrocardiographic monitoring is described in 
section 2.11.3, follow-up in section 2.13, and selection of controls in section 2.5.3.
7.2 Patients
Consecutive patients presenting with typical angina (section 2.9.1) were included. No 
patient had a prior myocardial infarction or a history of any other manifestation of 
coronary heart disease, or was taking long acting antianginal medication. Patients 
were excluded if they had baseline electrocardiographic abnormalities known to 
influence the ST segment such as left ventricular hypertrophy, bundle branch block 
or mitral valve prolapse, were on medical treatment likely to affect the ST segment, 
or had technically unsuitable ambulatory recordings. A total of 96 patients who did 
not meet any of the above exclusion criteria underwent 24 hour ambulatory ST 
segment monitoring prior to commencing antianginal therapy. Six patients were taking 
beta blockers for hypertension during the monitoring period.
Mean age of the 96 patients with typical angina pectoris was 57.5 (SD 9.9) 
years (range 34-70 years). Sixty-four were male and 32 female.
7.3 Ambulatory Electrocardiography in Patients with Angina
Fifty of ninety-six (52%) patients with angina had one or more episodes of significant 
ST segment depression during the 24 hour monitoring period. Prevalence of 
ambulatory ischaemia in men was 53 %, and in women it was 50%. Of a total of 225
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ischaemic episodes recorded, 159 (71%) were not accompanied by chest pain. There 
was no gender difference in the proportion of silent episodes - 70% in men and 73% 
in women. Of the 159 silent episodes, 89 (56%) were detected among 13 (14%) 
patients. Twenty-two per cent of angina patients had silent episodes only, and 24% 
had both silent and painful episodes (Figure 7.1).
The distribution of the number of ischaemic episodes recorded in men and 
women was similar (Figure 7.2). Among patients with ischaemic ST segment 
depression, men had a median of 3 (range 1-15) episodes and women 4.5 (range 1-15) 
episodes per 24 hour period respectively (p=NS). In men, the frequency of 
ambulatory ischaemia increased with age. Only 31% (5 of 16) of men up to the age 
of 50 had ischaemic episodes compared with 60% (29 of 48) of 51-70 year old men 
who had transient ischaemic episodes (p < 0.05). There was no statistically 
significant difference between men and women in the duration (median 59 vs 98 
minutes) or extent (mean 2.4 vs 2.5mm) of ischaemic ST segment change. In women, 
silent episodes lasted significantly longer than painful episodes (median 19 vs 11 
minutes, p < 0.05), but in men, painful episodes tended to be longer (median 14.5 
vs 10 minutes) although this difference did not reach statistical significance. However 
there was a large variation between patients in the total duration of ischaemia which 
ranged from 1 to 782 minutes with a median of 66 minutes (Figure 7.2). The 
circadian distribution of ischaemic episodes in both sexes was similar, with a primary 
peak between noon and 6pm (Figure 7.3). Sixty-one per cent of episodes in men and 
70% in women were accompanied by an increase in heart rate at onset.
7.4 Ischaemic ST Segment Depression in Asymptomatic Controls
Of 110 eligible asymptomatic controls, 95 subjects who did not have any of the 
exclusion criteria stated in section 7.2 underwent 24 hour ambulatory ECG 
monitoring. Mean age was 56.4 (SD 9.6) years, range 35-71 years; 59 were male and 
36 female.
Significant ischaemic ST segment depression was detected in 7 of 59 (12%) 
men and 2 of 36 (6%) women. Mean age of the 9 subjects with ischaemic changes 
was 64.3 (SD 4.6) years. A total of 21 episodes were detected during 2,453 hours of 
monitoring, and their circadian distribution was similar to that of angina patients, with 
an afternoon peak between noon and 6pm when 52% of the episodes were recorded.
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Median duration of episodes was 26 minutes (range 4-193 min.), and mean extent of 
ST segment depression 2.5 (SD 0.9) mm.
7.5 Symptoms, Cardiac Risk Factors and Ischaemic Activity
Table 7.1 shows the baseline clinical and exercise test characteristics of angina patients 
with and without ambulatory ischaemia. There were no significant differences between 
the two groups in frequency and duration of angina, gender or the major 
cardiovascular risk factors. Patients with ischaemia on ambulatory monitoring tended 
to be older and had a higher prevalence of exercise induced ST segment depression, 
but total exercise duration and the peak rate pressure product did not differ 
significantly between the two groups.
When the two groups were compared separately by gender, age, serum 
cholesterol and prevalence of exercise induced ST segment depression were 
significantly higher in men with ambulatory ischaemia (Table 7.2), but in women, 
only the latter was significantly higher. A stepwise multiple logistic regression 
analysis adjusting for age confirmed the independent association of serum cholesterol 
level with ambulatory ischaemic activity in men (Table 7.2).
7.6 Ambulatory Ischaemia and Event-free Survival
Follow up was complete for 93 of 96 (97%) angina patients. The remaining 3 patients 
had moved without a forwarding address. During a mean follow up period of 15.8 
months (range 7-30 months), there were 3 deaths, 8 myocardial infarctions, 7 coronary 
artery bypass graft operations and 11 coronary angioplasty procedures.
Seventeen patients (34%) with ambulatory ischaemia experienced adverse 
events compared with 12 patients (26%) with no ischaemia. Kaplan-Meier actuarial 
analysis of cumulative survival (Figure 7.4) revealed no significant difference in event- 
free survival between patients with and without ischaemia (66% vs 72%, p = NS). 
Slightly more patients with ambulatory ischaemia experienced the combined end points 
of death or myocardial infarction compared to patients with no ischaemia (14% vs 
9%), but again this difference was not statistically significant.
Survival was also compared in relation to duration of ischaemia. Eight of 26 
(31 %) patients with more than 60 minutes of ischaemia during 24 hours of ambulatory 
monitoring experienced events compared with 21 of 67 (31 %) patients with ischaemia
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less than 60 minutes or no ischaemia. Overall event-free survival in both groups was 
identical (69%).
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STD
(n=50)
No STD 
(n=46)
mean age (yr) 59.4 (9.2) 55.5 (10.3)*
male (%) 68 65
cigarette smokers (%) 28 37
hypertension (%) 52 48
serum cholesterol mg/dl 290 (54) 275 (50)
diabetes (%) 8 9
Symptoms
frequency ^  once daily (%) 36 33
duration < one month (%) 44 46
Exercise
STD 2> 1mm (%) 87 38 t
duration (min) 6.3 (2.5) 7.1 (2.8)
rate pressure product (xlO3) 27.7 (5.8) 29 (5.8)
STD =  ST segment depression 
value in parenthesis is standard deviation 
* p =  0.05 f  p <  0.001
Table 7.1 Baseline clinical characteristics of angina patients with and without 
ambulatory ischaemia.
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STD No STD p value
Univariate (n=34) (n=30)
mean age in years 60.3 54.4 0.02
serum cholesterol mg/dl 294 255 0.004
exercise STD ^  1mm (%) 84 38 <0.001
Multivariate Relative Risk (95% Cl) p value
serum cholesterol 1.9 (1.0, 3.4) 0.02
exercise STD 6.6 (1.8, 24.1) 0.003
STD =  ST segment depression ^  1mm
Table 7.2 Associations of ambulatory ischaemia in men by univariate and 
multivariate analyses.
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STD: +  or - pain 
24%
STD: silent only 
22%
STD: with pain 
6%
no STD 
48%
n = 96 patients
Figure 7.1 Nature of ischaemic ST segment depression (STD) in new patients 
with angina pectoris in the general population.
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■  male (n=64) ^ fem ale  (n=32)
0 1 2-5 6-10 11-15
Number of ischemic episodes per 24 hours
1-30 31-60 61-120 121-180 over 180
Duration of Ischemia (minutes)
Figure 7.2 Number of ischaemic episodes (top) and duration of ischaemia 
(bottom) recorded by 24 hour ambulatory electrocardiographic monitoring in men 
and women presenting with angina pectoris in the general population.
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Time of day (hours)
n = 225 episodes
Figure 7.3 Circadian distribution of ischaemic episodes in men and women 
with angina.
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Figure 7.4 Kaplan-Meier survival curves comparing cumulative proportion of 
angina patients surviving without cardiac events (death, non-fatal myocardial 
infarction, percutaneous transluminal coronary angioplasty or coronary artery 
bypass grafting) during mean follow-up of 15.8 months for 50 patients with 
ischaemia and 46 patients without ischaemia as detected by ambulatory 
electrocardiographic monitoring (STD = ST segment depression).
CHAPTER 8 
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8.1 Introduction
The majority of patients with angina pectoris are managed in the community yet since 
the advent of revascularisation there is very little contemporary information about the 
incidence, characteristics and natural history of this disease in the population. One of 
the reasons for the paucity of data is difficulty in obtaining access to angina patients 
in the population. Patients referred to hospital outpatient clinics are ‘survivors’ who 
are not representative of the broad spectrum of clinically manifest disease.
A further difficulty lies in the lack of a standard definition for the disease. 
There is an important distinction between angina defined by a questionnaire and 
clinical angina. Angina pectoris is a clinical syndrome where the diagnosis is made 
by a physician based on the patients reported symptom complex. An individual who 
responds positively to questions about chest discomfort in a questionnaire may not 
report any symptoms to his/her physician. Likewise, patients who report symptoms 
of typical angina to their physician may not satisfy the Rose questionnaire criteria for 
angina. Subjects with questionnaire positive angina may therefore not have the same 
characteristics as patients with clinical angina. This is supported by Rose’s (1978) 
observation that patients who present to their doctor seem to have prognostically more 
important disease compared with those who do not. A physician diagnosis of angina 
thus has a higher sensitivity for cardiac mortality (Kannel, 1972) compared with a 
questionnaire diagnosis of angina (Bulpitt, 1990). In this study therefore, the 
diagnosis of angina pectoris was made when the history reported to the physician 
matched the criteria of an anatomically (Weiner, 1979) and prognostically (Murabito, 
1990) validated definition.
This is the first study to investigate the clinical incidence and prognosis of 
angina since the advent of revascularisation. General practitioners’ perceptions of 
current angina management are discussed, followed by an appraisal of incidence and 
short-term prognosis of angina in the population.
One of the principal aims of this study was to investigate the clinical 
significance of ambulatory electrocardiographic monitoring in a representative sample 
of unselected incident angina patients. This is discussed in section 8.5.
8.2 Management of Angina Pectoris in the Community
The questionnaire survey (section 2.2) revealed striking differences in opinion among
99
a representative sample of general practitioners about the significance of symptom 
characteristics, the usefulness of exercise testing and the benefits of revascularisation 
for patients with angina. The majority of general practitioners appear to refer at most 
only a quarter of their patients with angina pectoris to a hospital physician, and only 
up to a tenth of all patients to a cardiologist at the regional centre. The findings 
suggest that unless symptoms are severe, investigation of patients with angina to 
determine suitability for revascularisation assumes a low priority. Whilst this is a 
survey of self reported referral practices without a formal audit of angina management 
in the surgeries, these findings are consistent with those of a cross-sectional survey 
which showed that of patients receiving medical treatment for angina from then- 
general practitioner, only 19% had attended a hospital medical clinic during a six 
month study period, 7% had had an exercise test, and 4% a coronary angiogram 
(Cannon, 1988).
Although symptoms of angina, both frequency and duration, are considered 
important by the majority of general practitioners in deciding when to refer a patient 
for investigation, over half do not think these are a reliable guide to severity of 
underlying coronary artery disease. This suggests the main reason for referring 
patients with angina is to improve symptom control rather than to determine the 
presence and significance of coronary artery disease, or to stratify for risk of future 
cardiac events. A referral policy based on symptoms may not be justified because 
symptoms are in general a poor guide to disease severity and long term prognosis 
(Hultgren, 1984). Furthermore the increased risk of cardiac events, particularly 
sudden death (Kannel, 1972), may depend on physiological significance of coronary 
artery disease rather than the severity of angiographic stenoses or symptoms alone. 
(Epstein, 1989). Therefore the presentation of angina, regardless of severity, would 
justify an exercise test to detect physiologically significant disease (Wilson, 1991), and 
age should not be a bar to investigation and revascularisation (RCP, 1991).
Over half of the general practitioners surveyed thought an exercise test was 
unnecessary for the majority of new patients with angina, or that it was required only 
in selected patients. By contrast, in a questionnaire survey of family physicians in the 
USA (response rate of only 34%) about exercise testing in patients with angina (Hartz, 
1989) 81% of the 265 physicians questioned said a non-invasive stress test should be 
ordered as part of the initial management plan for a patient with angina. However less
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than 40% accepted any given strategy for using the test result to make a decision about 
referring a patient to a cardiologist. These physicians seemed to know when to order 
the test, but were uncertain as to why they were ordering it and disagreed on how the 
test results should be used.
Although availability of exercise testing for general practitioners could be 
facilitated by offering open access to hospital facilities (Sulke, 1991), this survey 
emphasises the need for caution because most general practitioners are not exposed to 
this investigation routinely, and are therefore not confident at correctly interpreting the 
result. An exercise testing facility without the back up of a physician with 
cardiological experience to make management decisions would therefore be of limited 
value, and may be harmful to patients.
The survey revealed divided opinion among general practitioners about 
whether or not there is scientific evidence for the benefits of revascularisation. About 
a fifth did not know that coronary angioplasty relieves symptoms, and a similar 
proportion thought prolongation of survival following coronary angioplasty has been 
scientifically demonstrated although this is not the case (Nwasokwa, 1991). Likewise, 
about a fifth did not know whether coronary artery bypass surgery prolonged survival, 
and a further fifth considered such an operation to be of no value in relation to 
survival despite evidence to the contrary (Nwasokwa, 1991). These differences in the 
perception of trial results inevitably produce variation between general practitioners 
in the management of angina in the community, and are further compounded by 
disagreement among specialists about the appropriateness of coronary intervention 
(Brook, 1988). The lack of awareness among general practitioners of the benefits of 
coronary intervention and a low referral rate for investigation may, in part, be 
responsible for the low rate of revascularisation procedures per million population in 
the United Kingdom (Hubner, 1992; Unger, 1992).
Whilst there was a high response rate to this survey, a fifth of general 
practitioners did not participate and the practice of these non-responders is not known. 
Amongst the responders no distinction was made by year of graduation, possession of 
postgraduate diplomas or degrees, or whether the practice was fundholding or not, 
although these factors could influence the reported responses. If the respondents differ 
from a national sample of general practitioners they are likely to be less heterogenous, 
and therefore the variation in management of angina among other practitioners is likely
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to be at least as great as that found in this survey.
With the wide range of treatments now available to relieve symptoms, 
improve quality of life and prolong survival in selected patients with angina, the 
general practitioner has to choose patients for cardiological evaluation. This survey 
found that even though this disease has significant short term morbidity and mortality 
(Section 5.3), only a minority of patients with angina are reportedly referred to a 
general physician for investigation, and fewer still to a cardiologist. General 
practitioners expressed divergent and contradictory opinions about exercise testing and 
the scientific evidence for coronary angioplasty and coronary artery bypass surgery. 
These data provide a compelling basis for developing guidelines for the management 
of angina presenting in general practice in order to optimise the selection of those 
patients who are most likely to benefit from coronary intervention.
8.3 Incidence and Prognosis of Angina Pectoris
One of the aims of this study was to determine incidence and outcome of clinically 
manifest angina pectoris representative of the disease in the general population. 
Therefore, like the Framingham study (Kannel, 1972), the diagnosis of angina was 
based on a clinical history which is highly predictive of underlying coronary artery 
disease especially in men (Weiner, 1979), and which is prognostically validated by its 
independent association in both men and women with a three-fold increased risk of a 
non fatal or fatal cardiac event within two years of diagnosis (Murabito, 1990). 
Whilst the incidence of angina may be underestimated by missing those patients who 
do not report their symptoms to the general practitioner, those who do tend to be the 
ones with prognostically important disease (Rose, 1978). As general practitioners 
agreed to refer all new patients to the chest pain clinic, this study provides a useful 
estimate of the clinical incidence and prognosis of this disease based on a 
representative sample of unselected patients presenting with angina in the general 
population.
The crude incidence rate of angina in the present study is lower than 
previously reported (Table 1.2) and whilst differences between countries, patient 
populations, periods of study and methods make direct comparisons difficult, it is 
consistent with the 27 % decline in incidence of angina in 50-59 year old men in the 
Framingham cohort between 1950 and 1970 (Sytkowski, 1990). The rate reported by
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Fry based on 25 years of follow-up in a single south-east London general practice 
reflects an older population in which 56% of angina patients were over 60 years old 
at the time of diagnosis (Fry, 1976).
Incidence of angina increased in both sexes above the age of 50. The rate of 
increase diminished in women above this age, but in men the sharp rise continued such 
that 61-70 year old men had a four-fold higher incidence compared with 41-50 year 
old men and an almost three-fold higher incidence compared with women of the same 
age. In the present study the crude incidence rate of angina in women was about half 
that of men, consistent with the experience of Framingham women who over 26 years 
encountered half the coronary heart disease morbidity as men (Lemer, 1986). 
Biennial incidence rates for all cause morbidity from coronary heart disease in 
Framingham were also higher in men than in women, and in both sexes above 55 
years of age. But in women, the incidence of angina continued to increase in old age 
and was higher than in men above the age of 75. The reason for a higher incidence 
of coronary heart disease in women after menopause and the associated less favourable 
outcome compared to men is unclear, but the economic implications and need for 
further research in women are increasingly appreciated (Manolio, 1993).
The prognosis of patients who present to a general practitioner with exertional 
chest pain is not benign. About 10% in this study experienced myocardial infarction 
or death within one year of initial diagnosis. Some have classified new onset angina 
as ‘unstable’ implying the need for urgent treatment (Braunwald, 1989). However 
such a classification is of little practical value to a general practitioner to whom 
patients who ultimately follow a chronic stable course actually present with ‘new 
onset’ exertional chest pain. Extrapolating our data to the United Kingdom suggests 
that well over 2,000 patients present each year to general practitioners with exertional 
chest pain a few months prior to experiencing their first non-fatal or fatal myocardial 
infarction. Although the rates of myocardial infarction and death in men in the current 
study are similar to rates reported in a community study of men with unstable angina 
from selected general practices in Edinburgh (Duncan, 1976), they could 
underestimate the national rate for several reasons. Firstly, elective revascularisation 
in almost a fifth of patients may have averted an adverse outcome in a proportion of 
these patients. Secondly, as in a previous study (Fulton, 1972), it is possible some 
patients with chest pain did not present to their general practitioner or were not
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referred to the clinic for assessment, but subsequently experienced a cardiac event. 
The likelihood of this occurring is small because the general practitioners agreed to 
refer all patients and the provision of an open access chest pain service where such 
patients could be seen within 24 hours of presentation made referrals to any other part 
of the medical service unlikely. Lastly, because of known regional variation in 
incidence of coronary heart disease (Garg, 1992) and a lower standardised mortality 
ratio in the south-west (OPCS, 1991), incidence and mortality of angina in other parts 
of the United Kingdom are likely to be higher.
Like previous studies of angina in the population in which spontaneous 
remission of chest pain occurred in 14-39% of patients (Fry, 1976; Duncan, 1976; 
Kannel, 1978), spontaneous remission of symptoms occurred in 11 % of patients in this 
study, and with concomitant medical therapy in a further 19%. The reason for 
disappearance of symptoms without medication in this small proportion of patients is 
unclear. Angina is a clinical syndrome and therefore it is difficult to be certain 
whether remission is part of the natural history of the disease or was related to an 
‘incorrect’ initial diagnosis (Kannel, 1978).
The combined event rate for myocardial infarction and cardiac death in the 
current study was higher than the rate of cardiac events in patients with effort related 
angina admitted to a district general hospital (Murphy, 1992). In their prospective 
survey of admissions in whom cardiac enzymes had been measured, Murphy et al 
excluded patients with a confirmed myocardial infarction, and divided the remaining 
141 patients with angina into three categories: effort angina diagnosed by a modified 
Rose questionnaire, patients with confirmed prior infarction and those admitted with 
ST-T changes in association with chest pain. In contrast to the present study in which 
4 deaths and 8 myocardial infarctions were recorded within one year among 110 
patients with angina who were ambulant, none of the 35 patients with effort angina in 
that study experienced such events during the first 4 months after admission, and only 
2 events (6%) were recorded in the group after 3 years. Although a hospital study 
based on ‘survivors’ partly explains the low event rate, their results also underline the 
poor sensitivity of a Rose chest pain questionnaire diagnosis of angina for cardiac 
mortality. A diagnosis of angina based on a history elicited by a physician in the 
Framingham study (Kannel, 1972), as used in the present study, had a higher 
sensitivity for cardiac mortality than the Rose questionnaire which was used in the
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Whitehall study (Bulpitt, 1990).
Revascularisation rates in the current study and in the study by Murphy et al 
reveal striking differences in attitudes to coronary intervention amongst cardiologists 
in the United Kingdom. Compared to 18% of the community based ambulant cohort 
of patients with typical angina in the current study who underwent coronary 
angioplasty or coronary artery bypass grafting within one year of first presentation, 
in the study by Murphy et al (1992), only 12% (17 of 141) of patients with unstable 
angina had undergone revascularisation 3 years after initial hospital admission. Of 67 
patients in whom chest pain on admission was associated with resting ST-T changes, 
6 (9%) patients had undergone revascularisation within 3 years for persistent 
symptoms despite medical treatment, while 4 (6%) sustained a non fatal myocardial 
infarction and 18 (27%) patients died. Their data suggests that patients with unstable 
angina admitted to a ‘district’ hospital were managed more conservatively with regards 
coronary intervention procedures than outpatients with stable angina assessed by 
regional centre cardiologists in the present study.
This is the first survey of the incidence and short-term prognosis of angina 
pectoris since the advent of improved medical therapy and coronary revascularisation 
procedures. A major strength is its representativeness of clinically incident angina 
pectoris in the general population. Current incidence rates confirm the persisting sex 
differential in coronary heart disease. The apparent decline in incidence is consistent 
with the falling mortality from coronary heart disease.
8.4 Exercise Testing
Increasing reliance has been placed on non invasive tests to predict which patients with 
angina are at increased risk of future adverse cardiac events. Can exercise testing be 
used to refine the way in which patients are referred for bypass surgery? Studies 
evaluating the prognostic value of exercise variables have differed in their conclusions.
Non randomised studies of patients undergoing coronary angiography analysed 
on an ‘intention to treat’ basis suggest that survival varies according to stage of 
exercise attained and presence of ST segment changes (McNeer, 1978; Weiner, 1986). 
By contrast, in a prospective study of 838 patients following first myocardial 
infarction, the severity of angiographic disease, but not exercise induced ST segment 
changes, was predictive of future cardiac events (Ngo, 1990). Randomised studies
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comparing medical versus surgical treatment in patients with angiographic coronary 
artery disease also very in their results. While both the Veterans Administration 
(Peduzzi, 1986) and the European Coronary Surgery Study (Vamouskas, 1988) 
suggested that patients who develop ST segment depression at low workloads benefit 
from bypass surgery, in the Coronary Artery Surgery Study (Ryan, 1985), neither the 
degree of ST segment depression nor stage of exercise predicted benefit from surgery.
An important limitation inherent in most reports is ‘work up bias’, when the 
result of an exercise test influences the chance to be entered into the study (Philbrick, 
1982). The majority of studies include patients referred for cardiac catheterisation and 
are subject to this bias which is a source of considerable variance in the results, but 
which cannot be quantified (Detrano, 1989). In a study of 588 male veterans who 
were selected for coronary arteriography, exercise induced ST segment depression did 
not emerge as an independent predictor of infarct-free survival. However, when 
patients referred to the same institution who were not selected for cardiac 
catheterisation were studied, exercise workload and ST segment depression emerged 
as independent risk predictors of subsequent events (Brown, 1992). The authors 
concluded that work up bias was the likely explanation of the failure of exercise 
induced ST segment depression to be consistently chosen as a risk predictor (Morrow, 
1993).
The current study avoided referred bias by including consecutively referred 
new patients with typical angina from a randomly selected general population sample. 
The Framingham study which is the only other population based study of men and 
women with angina did not investigate the value of exercise testing.
While it was not a primary objective of this study, the study design provided 
a unique opportunity to prospectively investigate the prognostic value of exercise 
testing in a broad spectrum of new population based angina patients. The prevalence 
of a low workload positive exercise test among new angina patients was high at 29%. 
Clinical characteristics, and in particular the severity of angina symptoms did not 
identify patients likely to have marked exercise ischaemia at low workloads. More 
importantly, the frequency and duration of angina did not predict cardiac events.
Decreasing age and male gender were independently associated with increased 
risk of a cardiac event. This is likely to reflect the higher probability of 
revascularisation procedures in younger men.
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A total exercise duration < 6 minutes, but not exercise induced ST segment 
depression, was independently associated with reduced event free survival from all 
events ie PTCA, CABG, myocardial infarction or death. It was also independently 
associated with more than a three-fold increased risk of experiencing the objective end­
points of myocardial infarction and death. This study demonstrated that risk 
stratification of new patients can be simply based on total exercise workload attained. 
Exercise ischaemia was a poor predictor of cardiac risk. This is likely to be due to 
its poor specificity for prognostically important coronary artery disease especially in 
women. The results of this study of a representative sample of angina patients should 
be confirmed by a larger study with adequate statistical power.
8.5 Ambulatory Myocardial Ischaemia
Patient selection is critical to all scientific clinical investigations because it determines 
the generalisability of results. Previous studies of ambulatory electrocardiographic 
monitoring have included a variable number of patients with prior myocardial 
infarction (Rocco, 1988; Deedwania, 1990; Yeung, 1991; Mulcahy, 1992; Quyyumi, 
1993) or revascularisation (Rocco, 1988; Yeung, 1991; Mulcahy, 1992), are based on 
predominantly male patients (Tzivoni, 1989; Deedwania, 1990) with a low workload 
positive exercise test (Rocco, 1988; Tzivoni, 1989; Yeung, 1991; Deedwania, 1990) 
or angiographically proven coronary artery disease (Tzivoni, 1989; Quyyumi, 1993), 
and have all recruited patients referred to a specialist centre. With an increasing 
number of selection criteria, the spectrum of patients included becomes narrower, and 
the term ‘consecutive patients’ has no meaning when the population from which they 
are drawn is not known. To avoid these sources of bias, the present study was 
designed to investigate the frequency and prognosis of ambulatory ischaemia in a 
representative sample of new patients with angina from the general population typical 
of those who present in clinical practice. None of the patients had previously 
diagnosed coronary heart disease, and entry was not limited to patients with exercise 
induced ischaemia at low workloads or proven angiographic coronary artery stenoses.
8.5.1 Prevalence and Characteristics
Ischaemia during daily living activities was detected in half of all patients in this 
general population sample in whom angina pectoris was the first manifestation of 
coronary heart disease. There was no difference in the extent or duration of ischaemia
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between the sexes. Prevalence of ambulatory ischaemia in women in the present study 
was 50% compared with only 22% in a recently reported cohort of 121 women with 
coronary artery disease who underwent 48 hours of ambulatory monitoring (Thadani, 
1992). The lower prevalence in that study may be due to the inclusion of only 
selected women with mild or no symptoms, some of whom may have had a previous 
myocardial infarction (Pepine, 1991), whereas the present study was representative of 
all women in the general population up to the age of 70 years presenting with angina 
pectoris. Compared with asymptomatic controls, women with angina had a 
significantly higher prevalence of ischaemic ST segment depression during daily living 
which cannot therefore be regarded as all ‘false-positive’ even if the prevalence of 
significant coronary artery stenoses may be lower than in men with ischaemia (Welch, 
1975). The pathophysiological mechanism responsible for ST segment depression in 
women with angina may be different from that in men (Maseri, 1991).
Ambulatory ST segment depression was detected in 9% of ‘healthy’ 
asymptomatic individuals drawn from the general population. This may reflect 
underlying asymptomatic coronary artery disease as all were above the age of 55 years 
and at a higher risk for future cardiac events (Hedblad, 1989; Fleg, 1992). Reported 
frequency of ischaemic ST segment changes in selected healthy individuals ranges 
from 2% in hospital workers (Deanfield, 1984) to 30% in volunteer policemen 
(Armstrong, 1982). In the only other study of population based healthy subjects 
(Kohli, 1988), the reported prevalence of 12% was similar to the present study.
In this study, as in others (Mulcahy, 1988), the majority of ambulatory 
ischaemic episodes detected in patients with angina were not accompanied by chest 
pain. However the distribution of silent ischaemia was uneven and over half (56%) 
of all silent ischaemic episodes were detected in just 14% of the total study population. 
This is consistent with a study of 150 selected patients with clinically significant 
coronary artery disease in which over 50% of silent ischaemic episodes during 48 
hours of monitoring were concentrated in only 7% of patients (Mulcahy, 1988).
There were large differences between new angina patients in the number of 
transient ischaemic episodes and in the duration of ischaemia recorded over a 24 hour 
period. This inherent variability of ambulatory ischaemia, which has been quantified 
in patients with chronic stable angina (Nabel, 1987), emphasises the need for caution 
when interpreting data regarding therapeutic anti-ischaemic effects particularly if
108
criteria to take account of this variability are not used (Redl, 1990).
A circadian variation in the frequency of transient ischaemic episodes was 
evident in both men and women. A primary peak in the afternoon rather than in the 
morning hours in the current study is similar to observations in patients taking beta 
blockers (Deedwania, 1990), but is at variance with patients monitored off treatment 
in whom the primary peak of ischaemic episodes appeared to be in the morning hours 
(Hausman, 1990). While these differences could arise from the intrinsic variability 
of ambulatory ischaemia, they might also be due to influence of environmental factors 
which can modify the circadian pattern of heart rate change (Mulcahy, 1990). Thus 
patients with established chronic stable angina may modify their daily activity pattern 
to avoid peaks in daytime stress whereas the early afternoon peak in new patients in 
the present study probably reflects continuing occupational stress. The latter 
explanation is supported by a similar primary afternoon peak in the number of 
episodes of ST segment depression in the asymptomatic control population. The 
significance of the peaks in ambulatory ischaemic activity in relation to coronary 
events remains speculative because neither a direct causal relationship, nor a 
modification of outcome by medical intervention, has been demonstrated.
The relationship between the major cardiovascular risk factors and ischaemic 
activity during daily living in patients with angina was also investigated. In men, an 
elevated serum cholesterol level was positively associated with the presence of 
ambulatory ischaemic activity independent of age and baseline clinical characteristics. 
A similar relationship was not evident in women. This may be because women in the 
current study were of a predominantly post menopausal age group. Although 
incidence of coronary heart disease and prevalence of angiographic coronary artery 
stenoses are both positively associated with total cholesterol in women under 50, this 
relationship has not been demonstrated in older women (Kannel, 1971; Vliestra, 
1980), and there is no association between serum cholesterol and risk of sudden death 
(Cupples, 1992). Furthermore, in women, ST segment depression and normal 
coronary arteries can be associated with other factors such as hormonal status (Morise, 
1992) and may not represent prognostically important ischaemia. In contrast the 
independent association of raised cholesterol levels with ischaemic activity in men 
might underlie an important pathophysiological basis because cholesterol level is 
independently associated in men of all ages up to seventy years with both the short and
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long-term increased risk of sudden unexpected death (Cupples, 1992). While the 
association with raised cholesterol levels might reflect increased ischaemic activity due 
to more extensive coronary artery disease, other mechanisms associated with 
hypercholesterolaemia, such as endothelial dysfunction (Vita, 1990), increased 
hypercoagulability (Hunt, 1990) and enhanced platelet activity (Badimon, 1991) may 
be involved.
8.5.2 Ambulatory ischaemia and prognosis
In this study of patients presenting for the first time with angina pectoris in the general 
population, there was no statistically significant difference in event-free survival 
between those with and without ambulatory ischaemia. Ambulatory ischaemia 
remained prognostically unimportant even after women were excluded from the 
analysis. The findings of previous reports are contradictory. Ambulatory ischaemia 
predicts adverse coronary events in some selected patients with stable coronary disease 
(Rocco, 1988; Tzivoni, 1989; Deedwania, 19980; Yeung, 1991), but not in others 
(Mulcahy, 1992; Quyyumi, 1993). Deedwania and Carbajal showed an independent 
association of silent ischaemia with cardiac mortality in patients receiving medical 
treatment for angina (Deedwania, 1990), but unlike the current study of entirely new 
patients, the duration of symptoms in their study population of men with low workload 
positive exercise tests ranged from 2 - 4 2  years. By contrast, ambulatory ischaemia 
was found to be of no prognostic significance in 172 patients with stable angina 
selected non-consecutively from two centres (Mulcahy, 1992). In that study, the 
combined event rate for myocardial infarction and death was in fact two-fold higher 
in patients with no detectable ischaemia on ambulatory monitoring compared to those 
with ischaemia. A similar trend towards an increased event rate in patients without 
ischaemia was also found in a recent study by Quyyumi et al in asymptomatic or 
mildly symptomatic patients with coronary artery disease (Quyyumi, 1993). They 
used multiple criteria based on coronary angiography and exercise testing to select 116 
Tow risk’ patients, but as selection was based on coronary anatomy determined a 
mean of 2 years prior to enrolment, they could not include patients who had 
experienced an adverse event in the interim period, nor allow for any change in 
coronary anatomy during the 2 years following initial angiography. Furthermore their 
method of defining Tow risk’ using coronary anatomy and radionuclide 
ventriculography may not be entirely appropriate because in 5 of 6 patients, the most
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significant lesion at baseline angiography was not in the vessel that was totally 
occluded at the time of a subsequent acute clinical event, and the infarcted region in 
four of five patients did not show ischaemic dysfunction at the time of baseline 
radionuclide ventriculography (Quyyumi, 1993).
When patient selection is based on positive exercise tests at low workloads, 
the prognostic importance of ambulatory monitoring may be exaggerated because 
exercise induced ischaemia at low workloads not only predicts the presence of 
ambulatory ischaemia (Panza, 1991) but is also independently associated with an 
adverse outcome (Weiner, 1984). In such studies, patients with a high probability of 
having ischaemia recorded on ambulatory monitoring are therefore also the ones most 
likely to experience a cardiac event. It is therefore not surprising that in studies which 
based patient selection on a positive exercise test, ambulatory ischaemia appeared to 
have prognostic value (Rocco, 1988; Tzivoni, 1989; Deedwania, 1990), but in those 
which did not (Mulcahy, 1992; Quyyumi, 1993), including the current study, 
ambulatory ischaemia did not discriminate patients with an adverse outcome. 
Exercise-induced ischaemia probably results predominantly from increased demand 
across fixed, narrow lumen, flow-limiting stenoses associated with severe coronary 
atheroma, whereas ischaemic episodes during ambulatory monitoring may also occur 
at rest, and at lower levels of exercise, due to vasoconstriction and a reduction in 
coronary flow reserve associated with milder coronary artery disease (Cohn, 1992). 
Thus ischaemia in patients with low workload exercise tests which is mainly ‘demand’ 
related may be prognostically important, but ambulatory ischaemic ST segment 
depression which also occurs at rest due to altered vasomotor tone and 
vasoconstriction may have less prognostic importance.
In common with previous studies assessing the prognostic importance of 
ambulatory ischaemia (Rocco, 1988; Tzivoni, 1989; Deedwania, 1990; Yeung, 1991; 
Mulcahy, 1992; Quyyumi, 1993), in which the number of stable angina patients 
enroled ranged from 56 (Tzivoni, 1989) to 172 (Mulcahy, 1992), the number of 
patients in this study was small; therefore all studies lack adequate statistical power. 
The 95 % confidence interval for the observed difference in event rates of 6% between 
patients with and without ambulatory ischaemia in this study is -13% to +25%. So 
a much larger study would be required to detect with confidence, a clinically important 
difference of say 15%. A longer duration of follow up may also reveal a statistically
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significant difference in survival, but the prognostic value of ambulatory monitoring 
in predicting the objective end points of myocardial infarction and death diminishes 
over time (Yeung, 1991), and therefore it is likely that any difference in survival 
between patients with and without ischaemia would diminish.
As discussed earlier, the use of an exercise test to select patients for coronary 
angiography could have increased the chances of an association between ambulatory 
ischaemia and revascularisation procedures. This would have resulted in a higher 
event rate in patients with ambulatory ischaemia. Therefore this bias, if anything, 
strengthens the conclusion of this study in relation to the lack of prognostic importance 
of ambulatory ischaemia.
In order to evaluate the importance of ambulatory ischaemia in new patients 
with typical angina representative of those seen in clinical practice, cardiac 
catheterisation was not required for entry to the study, and therefore some patients 
may not have significant coronary artery stenosis. However comparisons with 
asymptomatic controls, especially in women, puts the reported prevalence of ischaemia 
in patients with angina into perspective.
In men, an association between ambulatory ischaemia and sudden cardiac 
death might be expected in view of the independent association of serum cholesterol 
level with each of these factors, but no conclusions can be drawn about this 
relationship from the present study because of the very small number of cardiac 
deaths. While a much larger study with sufficient end-points could address this 
important question, ambulatory electrocardiography is an insensitive marker of 
ischaemia related to a single vessel territory (Romeral, 1992) and is unlikely to have 
predictive value for sudden death if it is associated with a predominance of single 
vessel coronary artery disease (Drory, 1991).
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8.6 Conclusions
In summary, the annual clinical incidence of angina pectoris in the United Kingdom 
is estimated at 22,570 patients (95% Cl 17,840, 27,030). Of these, 9,370 men (95% 
Cl 7,760, 11,450) and 4,250 women (95% Cl 2,890, 5,330) can expect to have 
ischaemia (>  1mm ST segment depression) on exercise testing.
However in the generality of new patients with angina pectoris, exercise 
induced ischaemia appears to have no prognostic value. Furthermore, the severity of 
angina is a poor predictor of subsequent prognosis. On the other hand, a total 
exercise duration of < 6 minutes on the Bruce protocol treadmill test is independently 
associated with an increased risk of subsequent cardiac events.
Transient ischaemic episodes on ambulatory electrocardiographic monitoring 
occur in over half of patients presenting for the first time with typical angina pectoris 
in the general population. The pathophysiological basis of ischaemia may be different 
between the sexes, and in men, ischaemic activity during daily living is independently 
and positively associated with serum cholesterol. Ambulatory ST segment monitoring 
does not identify a subgroup at increased risk of death, myocardial infarction or future 
revascularisation. Therefore for the generality of patients presenting with angina 
pectoris, it is of no value in prognostic risk stratification and its use in routine clinical 
practice is not recommended.
The prognosis of incident angina is not benign. About 10% of new patients 
experience myocardial infarction or death within one year of presentation.
General practitioners’ knowledge about the prognostic value of angina 
symptoms, exercise testing and revascularisation shows a striking variation. The 
majority of patients with angina are reportedly not referred for cardiological 
investigation by their general practitioners.
8.7 Implications for Future Research
Non invasive tests used for risk stratification of patients with angina pectoris should 
be evaluated in a broad spectrum of unselected patients representative of the generality 
of disease encountered in clinical practice. Extrapolation of results from studies of 
selected patients referred to tertiary cardiac centres is inappropriate and can be 
misleading. At present the question of which non invasive investigation is optimum 
for prognostic risk stratification remains open.
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The severity of angina is an unreliable guide to subsequent prognosis. 
General practitioners would therefore be justified in referring all patients for further 
investigation. If this were to happen, then with current incidence rates, existing 
invasive and non invasive cardiological services in the United Kingdom would be 
overwhelmed. Further efforts should be directed at increasing general practitioners’ 
access to cardiological investigation, possibly through open access services. The 
important question of whether early cardiological assessment and revascularisation 
improve clinical outcome should be scientifically addressed in a randomised controlled 
trial.
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APPENDIX 1
Chest Pain Service : Angina Questionnaire
Q.No. |
(Please tick ( / )  appropriate box)
1. In a patient with stable angina do you consider symptom
characteristics in terms o f frequency and duration a reliable guide 
to the severity o f underlying coronary artery disease?
Yes No Don’t know
(i) Frequency | _ |  | _ |  | _ |
(ii) Duration |___ | |___| |___ |
2. For patients presenting for the first time with stable angina, and 
with no history o f CHD, an exercise test is
a) unnecessary in the majority o f patients |__ |
b) required in selected patients only |__ |
please specify...............................................................
c) necessary in the majority o f patients
3. Please rate the usefulness o f an exercise test for each o f the 
following indications:
1 2  3 4
Almost Some- frequently Almost 
never times useful always 
useful useful useful
5
Don’t
know
Screening asympto­
matic patients 
for CHD
For correct 
diagnosis o f 
angina
For assessing 
prognosis o f angina
For selecting patients 
with angina for 
coronary angio­
graphy
For reassurance
For arrhythmia 
assessment
For Office Use 
1 - 5
l _ l  6 
l_ l 7
l_ l 8
l_l 9
l_ l  10
l_ l  11
l _ l  12 
l_l 13
l_l 14 
l_l 15
l _ l  16
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4. How confident are you at correctly interpreting
Almost Sometimes Usually Always 
never confident confident confident 
confident
a) a resting ECG for signs 
o f ischaemia and
infarction: |_| |__ j |__| |__ |
b) an exercise test result:________ |_| |__ | |___| |___|
5. In your opinion, for stable angina patients, is there scientific evidence 
to show that:
(i) PTCA (Coronary angioplasty)
(a) relieves symptoms
(b) prolongs survival
If ves. for which age group?
Up to 65 years 
Over 65 years 
All ages 
Other
Specify..........................................
Yes No
a) Symptom 
relief
Don’t Know
b) Prolong 
Survival
Yes No Don’t know
(ii) CABG (Coronary arteiy bypass 
surgery)
(a) relieve symptoms
(b) prolongs survival
If ves. for which age group?
Up to 65 years 
Over 65 years 
All ages 
Other
Specify.............................................
a) Symptom 
Relief
b) Prolong 
Survival
For Office Use
l_ l 17
l_ l 18
l_ l 19 
l_ l  20
l_ l  21 
l_ l  22
l _ l  23 
l _ l  24
l _ l  25
l _ l  26
l _ l  27
l_ l 28
l _ l  29 
l_ l 30
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6. How important do you consider each of the following criteria when 
deciding to refer patients presenting for the first time with angina 
for assessment by a hospital Cardiologist?
1 2 3 4
Very Of Of Of no
Important moderate little importance 
importance importance
Age | _ |  | _ |  | _ |  l _ l
Sex | _ |  | _ |  l _ l  l _ l
Family history o f CHD |___ | |___ | |  | | ___|
Presence o f Hypertension |___ | |___ | |  | |___|
Diabetes | _ |  | _ |  | _ |  | _ |
Cholesterol level |___ | |__ | |___ | | ___|
Smoking status |  | |__ | |___ | |___|
Duration o f symptoms |___ | |__ | |___ | |___|
Frequency o f symptoms |___ | |__ | |___ | |___|
Amount o f exertion required
to produce symptoms |  | |___| |___ | |___ |
Symptoms at rest (as well as
on exertion) |  | | ___| |___ | |___ |
Normal resting ECG |  | | ___| |___ | |___ |
ECG evidence o f ischaemia |  | |___| |___ | |___ |
ECG evidence o f myocardial
infarction I I  I I | | I |
Other: please specify:
Would you refer all patients with angina for hospital assessment 
irrespective o f above criteria.
Yes | |
For Office Use
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
No l_ l 46
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7. What proportion o f your stable angina patients are For Office Use
None Up to Up to Up to Up to All 
10% 25% 50% 75%
Referred to a general 
hospital physician l_ l 47
Referred directly to a 
Cardiologist at the 
regional centre. I_ l 48
8. At present, when you refer a patient presenting for the first time with 
suspected angina to a hospital Out Patient Clinic for consideration o f an 
exercise test, in your estimate how long does it take from the date o f referral 
to the time that the investigation results and management plan are made 
available to you?
9. If an open access clinic providing a complete initial cardiological assessment 
(including exercise testing and advice on recommended management by a 
Registrar) was available to you for referral o f new suspected angina patients 
would your referral rate o f such patients to a hospital consultant physician’s 
out patient clinic
a) stay the same |__ | |___| 52
4 9 - 5 1
b) decrease _ |  53
c) mcrease _ l  54
Would you utilise such a clinic?
Yes _ |  55
No
ANY OTHER COMMENTS:
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APPENDIX 2a
Angina Study : GP Coding
Surgery Practice Code GP Code G .P.s
Blackthorn Surgery 001 01 Goodison S.F.
73 Station Road 02 Wilson D.
Netley Abbey 03 Laing H.C.
Southampton 04 Steer J.M.
S03 5AE 05 Lennon A
Tel. 453110 06 Thomson M
Prac.Mgr. Mrs. Jean Hay
The Surgery 002 01 Blount A.
112 Shirley Road 02 Davidson S.I
Southampton SOI 3FS 03 Brooke M.J.
Tel. 221964
Prac.Mgr. Mrs. Jean Parker
The Green Park Surgery 04 Barnes R.C.
22 Wimpson Lane 05 Simpson R.L.
Southampton SOI 4QF 06 Simpson Rosalind M,
Tel. 774853
Prac.Mgr. Mrs. Marion Nelson
The Medical Centre 003 01 Gordon A.D
Hythe 02 Cunliffe J.
Southampton S 0 4  5ZB 03 Davidson K.
Tel. 845955
Off.Mgr. Mr. A.E. Lord
Blackfield Medical Centre 04 Gregory.P
Blackfield 05 Vincent S.
Southampton S 0 4  1XA 06 Greaves F.
Tel. 899119 07 R ialS.
Prac.Mgr. Mrs. S. Augustus
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Surgery Practice Code GP Code GP.s
1 Shirley Avenue 004 01 Gilbert M.
Shirley 02 Knight A.O.C.
Southampton 03 Stringfellow M
S 09  2UP 04 Pringle J.
Tel. 771356
1 Cheviot Road, 05 Murphy C
Millbrook, 06 Kelpie A.
Southampton SOI 4AH 07 Patten T.
Tel. 773174 08 Tiller G (R)(p/t)
Prac.Mgr. Mrs. J. Hunt
68 Alma Road 005 01 Lee R.D.
Portswood 02 Woodbine G.
Southampton 03 Yardley D .N .
S09 4TR 04 Lawrence I.
Tel. 551555 05 Ord-Hume G.
Prac.Mgr. Mr. Tom Shaw
06 Westensee W.
The Medical Centre 006 01 Husband P.
Hythe 02 Bolt S. A.
Southampton 03 Radcliffe M.J.
S 04  5ZB 04 Newton D.J.
Tel. 845955 05 Hill-Cousins S.T,
Prac.Mgr. Mrs. Julia Pegg
The Surgery Husband P.
Old Malthouse Bolt S.A.
Main Rd. Radcliffe, M.J.
March wood, Newton D.J.
Southampton S 04  4UZ. Hill-Cousins S.T,
Tel. 871233
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Surgery Practice Code GP Code GP.s
Testvale Surgery 007 01 Crawford V.
12 Salisbury Road 02 Dracass J.
Totton 03 Hunter S.
Southampton 04 Entwisle I.
S 04  3PY 05 Zardis M.
Tel. 866990 06 Whitfield S. (T)
Prac.Mgr. Mrs. Linda Millard
4 Chessel Avenue 008 01 Nicholls M.J.
Bitteme 02 Plumptre A.M .
Southampton 03 Bradberry S.W.
S 09 3U 04 Fisher. M.S.
Tel. 447777 05 Maclean J.K.
06 Shaw K.I.
07 Bute K.J.
Prac.Mgr. Mrs. Angela Tipper
Lordshill Health Centre 009 01 Mansbridge.B.J.
Lordshill District Centre 02 Billington T.R.M,
Lordshill 03 Bainbridge B.M.
Southampton 04 Fung P.J.
SOI 8HY 05 Bamfield M.
Tel. 738144 06 Gray B.
Prac.Mgr. Mrs. J. Gingell
07 Watson T. (R) 
Teddels S. (T)
Shirley Health Centre 010 01 Mansfield J.E.
Grove Road 02 Nightingale J.H.
Shirley 03 Walton R.J.
Southampton 04 May P.G.R.
S 09  3ZA 05 Short P.M.
Tel. 783611 06 Clouter C.A.
07 Donnelly P. (T)
08 Vyas D. (T)
Gen.Mgr. Mrs. Brenda Sawyer
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Surgery Practice Code GP Code GP.s
Group Practice Centre O il 01 Trickett A.C.H.
Victor Street 02 Johnson W.J.
Shirley 03 Hutchin A.K.M.
Southampton 04 Varney P.R.
S09 5HL 05 Pitt I.
Tel. 774781 06 Stephens C.R.
07 Glasspool J.A.
Prac.Mgr. Mrs. Norma York
08 Graham J.
Bath Lodge Practice 012 01 Gray P.J.
Bitteme Health Centre 02 Hayes N.R.
Commercial Street 03 Rolles T.F.
Bitteme 04 Paynton D.J.
Southampton 05 McKay A.
S09 2DA 06 Davidson P.H.
Tel. 442111 07 Godwin D.S. 
Ayoub S.A. (T)
Prac. Mgr. Mrs. D. Parsons
Forest Gate Surgery 013 01 Leftley P.
Hazel Farm Road 02 Bramley K.W.
Totton 03 Parry K.T.
Southampton 04 Newman C.J.
S 0 4  3WU 05 Ayres C.M.
Tel. 663839 06 Detsios C.
Prac.Mgr. Mrs. N. Head
The Medical Centre 014 01 Hamilton A.C.E,
Hythe 02 Bedford B.
Southampton 03 Pitts J.R.
S 04  5ZB 04 Campbell D.R.
Tel. 845955 05 Allen A. P.
06 Whitby M.E.
Blackfield Medical Centre 07 Varney A .D.
Hampton Lane 08 Hoegan R. (T)
Blackfield 09 Ellis J. (T)
Southampton S 04  1XA. Hoegan (T)
Administrator Mrs. S. Augustus
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Surgery Practice Code GP Code GP.s
The Surgery 015 01 Waddington G.E.
6 Stoneham Lane 02 Fitzpatrick W.J.
Swaythling 03 Hannan A .N.
Southampton 04 Lloyd C.N.
S09 4NB 05 Cunningham L.M.
Tel. 555776 06 Hubbard M. (T)
Prac.Mgr. Mrs. P. Watkins
The Health Centre 016 01 Munro M.R,
Testwood Lane 02 Wood T.A.
Totton 03 Stobbs I.P.
Southampton 04 Darch M.H.
S 04  3AP 05 Boyd U.B.
Tel. 865051 06 Godfrey S.
Prac.Mgr. Mrs. J. Atkinson
St Mary’s Surgery 017 01 Coleman G.P,
James Street 02 Munro W.P.
Southampton 03 Percy D.B.
SOI 1PJ 04 Prichard P.
Tel. 333778 05 Booth K.
06 Buis C.(T)
07 Bames K. (T)
Prac.Mgr. Mrs. Barbara Avery
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Invitation to Healthy Controls
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APPENDIX 3
Date
Dear
I am writing to ask if you could help with a special research project on Heart Disease. 
Your name has been chosen completely at random and you are one of several people 
who are being approached in this way.
You will have a complete heart check, including a recording of your heart (ECG) and 
a short fitness test on a treadmill whilst your heart is being monitored, so wear casual 
clothes and comfortable walking shoes. A blood sample will be taken to measure your 
cholesterol level. Your visit to the hospital will take approximately 1-2 hours.
In the hope that you will help we have reserved a personal appointment for you at the 
Non-Invasive Cardiology Department
on at
A map is attached and you are advised to allow sufficient time for parking.
This service is supported by your family doctor and I hope you will make use of it. 
You will benefit from a full heart check-up, whilst at the same time, making an 
important contribution to medical research.
Please complete and post back the enclosed reply slip in the pre-paid envelope 
provided as soon as possible.
If the appointment is not convenient please contact Mrs. Linda Truscott on the above 
telephone number, extension 2842, so that we can offer you an alternative.
Yours sincerely,
Dr M M Gandhi 
Clinical Research Fellow
Att.
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APPENDIX 4
CHEST PAIN SERVICE 
Monday to Friday 9 am - 1 pm 
REFERRAL FORM FOR NEW PATIENTS WITH CHEST PAIN
Date_________
To: Non-Invasive Cardiology Referring Doctor
Outpatients Department
Royal South Hants Hospital ______________
Graham Road
Southampton___________________ ______________
S09 4PE
Tel: 634288 Ext: 2842/2961 ______________
Patient Name 
Address:
Current Medication:
PLEASE COMPLETE AND SIGN THE CHEST X-RAY REQUEST CARD 
ATTACHED TO THIS FORM
Signed:.
Consent Form
138
APPENDIX 5
N am e..................................................................................................
I agree to undergo a heart check which will involve the following:
(i) An interview and physical examination by a Doctor.
(ii) Giving of a blood sample.
(iii) An exercise test on a treadmill which will be medically supervised and has no 
greater risk than a vigorous walk uphill.
(iv) A 24 hour tape recording of the heart beat using a light portable tape.
I understand the main results will be sent to my General Practitioner and also used for 
medical research.
Signature Date
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APPENDIX 6
CHEST PAIN SERVICE
QUESTIONNAIRE
Please answer the questions in this record as far as you are able bv ringing the appropriate  
answer.
If you have any questions or problems do not hesitate to ask the staff.
All the information recorded in this personal health record will be treated as strictly confidential. 
The results, which you will be told about at the end o f  the examination, will be used for research 
into coronary heart disease but only in the form o f  general statistics from which it will be 
impossible to identify you as an individual.
A report o f  the examination and any further tests will be sent to your general practitioner. 
Thank you for your co-operation in this study.
CHEST PAIN SERVICE
Study Number 
Practice Code 
General Practitioner
Please write your name and address in full.
NAM E ........................................
ADDRESS ........................................
POSTCODE ...........
TEL.NO. Home
Work
DATE
Your General Practitioner’s name:
Section Number 
Study Number 
Practice Code 
General Practitioner
I would be grateful for some personal information first
(Please circle the appropriate answer 
or write in space provided)
1. What is your date o f  birth?
2. What is your sex?
Male Female
3. What is your country o f  origin?
England 
Other 
If other please specify
(e .g . Rep. o f  Ireland, Indian, Afro Caribbean, etc)
4 . What is your marital status?
Single Married Widowed
Separated Other
6. What kind o f  work have you done for the longest period 
o f  your life?
Please give the name o f  the job and describe what you do 
or did as fully as possible.
7. What business or industry is or was this in?
8. For how many years have you done or did you do 
this work?
.................................................years
For Married Women
9. What kind o f  work has your husband done for the longest 
period o f  his life?
Please give the name o f  the job and describe what he does 
or did as fully as possible.
10. What business or industry is or was this in?
11. For how many years has he or did he do this kind 
o f  work?
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Section |__ |__ | 1 - 2
Study l _ l _ l _ l _ l _ l  3“ 7
I  w o u ld  l ik e  to  a s k  y o u  a b o u t  y o u r  m e d ic a l  h is to r y
(Please circle the appropriate answer or write in the space 
provided)
12. Have you ever been told by a doctor that you have, 
or have had, any o f  the following:-
(a) Heart trouble Yes No l _ l  8
(b) Rheumatic fever Yes No l _ l  ^
(c) Angina Yes No l _ l  io
(d) Heart attack Yes No l _ l  11
(e) Coronary thrombosis Yes No l _ l  12
(f) Myocardial infarction Yes No l _ l  13
If  YES, please specify
(g) High blood pressure Yes No l _ l  14
(h) Stroke Yes No l _ l  15
(i) Diabetes Yes No l _ l  16
(j) Hardening o f  the arteries 
in the legs Yes No ! _ J  n
(k) Hiatus hernia Yes No l _ l  18
(1) Gallstones/gallbladder 
disease Yes No l _ l  19
(m) Peptic (stomach or 
duodenal) ulcer Yes No l _ l  20
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13. Are you on any regular medical treatment at present from 
a doctor for any condition?
Yes No
If ‘YES’ please list:
Name o f  Condition
Medication
1 ..................................................................................................
2.........................................................................................
 3.............................................................................................................
 4.............................................................................................................
 5.............................................................................................................
 6...............................................................................................
 7....................................................................................................... .
 8...............................................................................................
9 .............................................................................................................
14. D o you get pain or discomfort in your chest?
Yes No
15. How long does/did the discomfort last?
...............Hours ................Minutes  Seconds
N ot applicable
16. D o you get it when you walk uphill or hurry?
Yes No
I never hurry or walk uphill
17. D o you get it when you walk at an ordinary pace on the 
level?
Yes No
l_ l  21
_  122-23  
_  124-25  
_  126-27  
_  128-29  
_  130-31 
_  132-33  
_  134-35  
_  136-37  
_  138-39
l_ l  40
I I I I I I 141-46
l _ l  47  
l__l  48
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18. What do you do if  you get it while walking?
Stop or slow down Carry on |  | 49
19. I f  you stand still, what happens to it?
Relieved Not relieved |  | 50
20 . How soon?
10 minutes More than 10 minutes_______________________________________ | ___| 51
21. What was/is the nature o f  the pain or discomfort?
Stabbing |  | 52
Dull ache |  | 53
Burning |  | 54
Tight | _ |  55
22. Please indicate the site o f  the pain
Sternum (upper or middle) |___ | 56
Sternum (lower) |___ | 57
Left anterior chest |___ | 58
Left arm |___ | 59
Other I I 60
23. Did/do you feel it anywhere else? 
Yes No
If YES, please describe where
24. Have you ever experienced chest pain or discomfort during 
sexual intercourse?
Yes
No
Not Applicable 
If YES, has this occurred:
Once or twice only
Frequently
Not applicable
25. Have you ever had a severe pain across the front o f  your 
chest lasting for half an hour or more?
Yes No
26. Do you suffer from indigestion?
Yes No
27 D o you consider yourself to be under "stress"?
Yes No
If Y ES, please describe why
Section
Study No.
Family History
(Please circle the appropriate answer or write in the space 
provided)
28. Is there a family history o f  heart disease?
Yes No
If  YES, please detail
Relation- Age when Diagnosis
ship(incl heart
sex) disease
developed
Alive or 
dead includ­
ing age at 
death
2 9 .Has anyone in your family ever had diabetes? 
(Sugar disease)?
Yes No
If  Y ES, which o f  your relatives 
(eg brother, cousin, parent)?
30. Has anyone in your family ever had high blood pressure?
Yes No
I f  YES, which o f  your relatives 
(eg brother, cousin, parent)?
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31. For Women Only 
Have you ever had:-
a) The contraceptive pill Yes No | ___i 15
b) Hormone replacement
therapy (HRT) Yes No | ___| 16
c) A  hysterectomy Yes No | ___| 17
d) An oophorectomy
(ovaries removed) Yes No | ___| 18
I would like to ask some questions about smoking
(Please circle the appropriate answer or write in the space 
provided)
32. D o you smoke?
Yes No |  | 19
If  N O . proceed to question 37
33. What do you usually smoke?
Cigarettes Yes No | __ | 20
Pipe Yes No |__ | 21
Cigars Yes No | __ | 22
34. How many do you usually smoke?
Cigarettes per day   |__ | ___123-24
Ozs o f  tobacco per day ......................................... J___|__ |__ J 25-27
Cigars per week   |__ | ___128-29
35. What brand do you usually smoke?
.................................................................................................  | _ l  30
36. For how many years have you smoked during your life? |__| ___131-32
.....................................years
Proceed to question 42 .
149
37. Have you ever smoked regularly since you left school?
Yes No j__ | 33
I f  N O . proceed to question 42
38. What did you usually smoke?
Cigarettes Yes No | __i 34
Pipe Yes No | __| 35
Cigars Yes No | __| 36
39. How many did you usually smoke?
Cigarettes per day   | ___ |__ 137-38
Ozs o f  tobacco per week ......................................................... |__ |__ |__ 139-41
Cigars per week   |___ |__ 142-43
40. For how many years did you smoke?
..................................years | __ |__ 144-45
41. How long is it since you finally gave up smoking?
..................................months/years | __ |__ 146-47
T w ould like to ask you about vour drinking habits
(Please circle the appropriate answer or write in the space 
provided)
42. Do you drink alcohol?
Yes No
If NO. proceed to question 46
43. Think carefully back over die last seven days.
Please tell me exactly what alcoholic drinks you have 
consumed on each day during the past week.
For each day I would like to know:-
i) the number of pints of beer, lager, shandy, cider,
stout etc.
ii) the number of single glasses of whisky, vodka, gin,
rum etc.
iii)the number of single glasses of Martini, port, sherry, 
wine etc.
that you have drunk. Try to remember where you were 
and who you were with on each day. This may help you 
remember what you have had to drink.
Pints of 
Beer etc
Single glasses 
spirits
Single glasses 
wine etc.
Monday
Tuesday
Wednesday
Thursday
Friday
Saturday
Sunday
Number of units per week
44. Would you say that last week was fairly typical of what 
you usually have to drink in a week?
Yes No
45. If last week was not typical, would you normally drink 
more or less in a week?
More Less
46. Have you ever drunk alcohol? 
Yes No
Thank you for completing the questionnaire.
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APPENDIX 7
EXAMINATION RECORD 
HISTORY
Date:....................... Name:............
Age:..............
Study Number:
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Section I | | 1-2
Study Number |__|__|__|__|__| 3-7
1. Classification
Typical angina = 1 Myocardial infarction = 5  |__| 8
Non-cardiac pain = 2 Unstable angina = 6
Possible angina = 3 Exclusion = 7
Atypical pain ?cause = 4
2. Clinical examination
Weight (kg) |__|__|__| . |__| 9-12
Height (m) |_| . |  | | 13-15
Body mass index (calculated) |_| | . |  | 16-18
3. Blood pressure Systolic | | |  | 19-21
Diastolic |  | |  | 22-24
Heart Rate I _  I _  I _  I 25-27
Rhythm |__| 28
4. Stigmata of hyperlipidaemia
Arcus Yes = 1  No = 2 |__ | 29
Xanthelasmata Yes = 1  No = 2 |__ | 30
Xanthomata Yes = 1  No = 2 | | 31
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Investigations
5. Resting ECG recorded Yes = 1 No = 2 |__| 32
If NO, specify reason:....................................
Rate/min I_I I | 33-35
Rhythm I__I 36
PR I i I 37-38
Axis________________________________________________ I_I I I 39-41
QTc l _ l _ l  42-43
ST-T change Yes = 1 No = 2 |_ J  44
6. Exercise ECG tests Yes = 1 No = 2 |___I 45
If NO specify reason:.....................................
7. 24h ambulatory ECG Yes = 1  No = 2 |___| 46
If NO specify reason:.....................................
8. Chest X-Ray Yes = 1  No = 2 |___I 47
Findings:..........................................................
9. Serum cholesterol Yes = 1 No = 2 |___| 48
10. Random blood glucose Yes = 1 No = 2 |___J 49
11. Biochemistry Yes = 1  No = 2 |___| 50
12. FBC Yes = 1 No = 2 | _ |  51
13. Other  Yes = 1 No = 2 | _ |  52
14. Date seen___________________________________ |__|__|__|__|__|__[53-58
EXAMINATION RECORD (CONTROL)
HISTORY
Date: Name:..............
Age:.................
Study Number*
Section
Study Number
Classification
Suitable control = 1
History of angina 
(undiagnosed previously) = 2
Exclusion:
known PMH of CHD = 3
Exclusion:
Left bundle branch block = 4
Clinical examination 
Weight (kg)
Height (m)
Body mass index (calculated)
Blood pressure
Heart Rate 
Rhythm
Yes 
Yes 
Yes
Stigmata of hyperlipidaemia 
Arcus
Xanthelasmata
Xanthomata
Exclusion:
mitral valve prolapse 
Exclusion:
LVH with ST changes
Exclusion:
Other criteria
Systolic
Diastolic
1 No = 2
1 No = 2
1 No = 2
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Investigations
5. Resting ECG recorded Yes = 1  No = 2 | | 32
If NO, specify reason:....................................
Rate/min I_I I | 33-35
Rhythm I I 36
PR l _ l _ l  37-38
Axis I_I I I 39-41
QTc l _ l _ l  42-43
ST-T change Yes = 1 No = 2 | _ |  44
6. Exercise ECG tests Yes = 1 No = 2 | | 45
If NO specify reason:.....................................
7. 24h ambulatory ECG Yes = 1  No = 2 | | 46
If NO specify reason:.....................................
8. Chest X-Ray Yes = 1 No = 2 | _ |  47
Findings:...........................................................
9. Serum cholesterol Yes = 1 No = 2 |___ | 48
10. Random blood glucose Yes = 1  No = 2 |___| 49
11. Biochemistry Yes = 1  No = 2 |__ | 50
12. FBC Yes = 1 No = 2 | _ |  51
13. Other  Yes = 1 No = 2 | _ |  52
14. Date seen I I I I I I I 53-58
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Angina Study : Cholesterol. Glucose, symptom duration, management.
Study Number | _
1. Serum Cholesterol
2. Plasma Glucose
3. Duration of Symptoms (days)
4. Medical treatment initiated for angina 
(long acting nitrates, calcium antagonist
and/or beta blocker) 1 = Yes
2 = No
5. Antihypertensive medication (new) prescribed 1 = Yes
2 = No
6. Frequency
7. Which antianginal?
. I _ l _ l  1-5
_ U _ I  6-8 
_ U _ I  9-11
I I 112-15
l_ l  16
!_ l  n
l_ l  18 
l_ l  19
File number (where different from Study Number):
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Codes Re : Cholesterol. Glucose, symptom duration, management
No. Box numbers Code
1-5 Study Number
1. 6-8 Random serum cholesterol (mmol/L)
99.9 = not available
2. 9-11 Random plasma glucose (mmol/L)
99.9 = not available
3. 12-15 Number of days (prior to date of clinical attendance) since symptoms
first started.
4. 16 0 = Not applicable
1 = Yes
2 = No
3 = Hospital admission due to myocardial infarction 
prior to exercise test.
4 = Hospital admission for another reason prior to
exercise test.
5. 17 1 = Yes
2 = No
6. 18 1 =  more than once a day
2 =  Once daily
3 = 4 -6  times a week
4 =  Up to 2 - 3 times a week
5 =  Once a week
6 =  Less than once a week
7 =  Single episode only
160
7. 19 1 = Beta blocker
2 = Calcium antagonist
3 = Long acting nitrate
4 = Any combination
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APPENDIX 8
Angina Study : Resting Electrocardiograph
Section Number 
Study Number 
Date of ECG
1. O and OS patterns 
Anterolateral site (I, aVL, V6)
Inferior site (II, HI, aVF)
Anterior (VI V2 V3 V4 V5)
2. ORS Axis
See Coding Sheets
3. ST segment depression 
Anterolateral (I, aVL, V6)
Inferior (H, HI aVF)
Anterior (VI V2 V3 V4 V5)
4. T wave items 
Anterolateral (I, aVL, V6)
Inferior (H, IH aVF)
Anterior (V2 V3 V4 V5)
5. A-V Conduction defect
Specify............................................................
PR interval
6. Ventricular conduction defect
Specify.............................................................
7. Heart Rate 
Arrhythmias
Specify.............................................................
| _01 _ 111- 2
|  |  13- 7
 | 18-13
_ |  114-16
_ |  117-19
_  | 120-22
_  |  123-24
_ | _ |  25-27 
_ | _ |  28-30 
_ |  131-33
 | |34-35
_ l _ l  36-37
_ |  138-39
_ |  |40-42
I 143
I__ i144-46
|47-49
150-52
ST segment elevation: Anterolateral (I, aVL, V6)
Inferior (II, III aVF) 
Anterior (VI V2 V3 V4 V5)
Miscellaneous
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Angina Study : Resting Electrocardiograph Codes
Question
1. Q.QS patterns
2. QRS axis
3. ST depression 
(STD)
Box numbers 
1-2 
3-7 
8-13 
14-16 
17-19 
20-22
23-24
25-27
28-30
31-33
Coding
01 = Section Number 
Study Number 
Date of ECG 
anterolateral (I, aVL, V6) 
inferior (II, III, aVF) 
anterior (VI V2 V3 V4 V5)
000 = No Q wave present
When Q wave present in any lead(s) refer to summary 
of ‘Minnesota Code 1982’ and choose from 
Code 111 through 136 
for each set of 3 boxes.
20 = Normal axis
21 = Left
22 = Right
23 = Right Optional
-29° through +89° 
-30° through -90°
+120° through -150° 
+90° through +119°
DO NOT CODE IN PRESENCE OF:
91 = Low QRS amplitude (see Code 9-1, page 129) 
LBBB or RBBB 
00 = Not codable.
Anterolateral (I, aVL, V6)
Inferior (II, HI, aVF)
Anterior (VI V2 V3 V4 V5)
000 = No horizontal/downward sloping STD
For horizontal/downward sloping STD:
411 = > 2.0 mm
412 = > 1.0 mm but < 2.0 mm 
420 = > 0.5 mm and < 1.0 mm
(Select boxes appropriate to lead(s))
999 = Not codable.
(eg in presence of bundle branch block).
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4. T wave
5. AV Conduction
6. Ventricular 
Conduction
7. Heart Rate 
Arrhythmias
34-35 Anterolateral (I, aVL, V6)
36-37 Inferior (II, III, aVF)
38-39 Anterior(V2 V3 V4 V5)
00 = No T wave changes.
(Read full codes on page 126)
51 = T negative ^ 5 .0  mm
52 = T negative or diphasic ^ 1 .0  mm but < 5.0 mm
53 = T flat, negative or diphasic <1 .0  mm
99 = Not codable
(in presence of WPW or bundle branch blocks)
40-42 Select from Codes 610 through 680
(page 127 Minnesota Code Summary)
000 = No AV conduction abnormality
43 PR interval
1 =  <  0.12
2 =  0 . 12 - 0.20
3 = 0.21 - 0.22
4 = > 0.22
44-46 711 = Complete LBBB
712 = Intermittent LBBB
721 = Complete RBBB
722 = Intermittent RBBB 
730 = Incomplete RBBB 
740 = Intraventricular block 
750 = R-Rl with R1 ^  R 
760 = Incomplete LBBB
47-49 Heart Rate (beats/min)
(Page 127 Minnesota Code Summary)
50-52 See page 128, Minnesota Code Summary 
Selected examples of codes:
812 = Frequent ventricular premature beats
831 = Atrial fibrillation (persistent)
832 = Atrial flutter (persistent)
870 = Sinus tachycardia (> 100/min)
880 = Sinus bradycardia (< 50/min)
000 = No codable arrhythmia
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8. ST elevation
9. Miscellaneous
53-54 Anterolateral (I, aVL, V6)
55-56 Inferior (II, HI aVF)
92 = ST elevation ^  1.0 mm in any lead
57-58 Anterior (VI V2 V3 V4 V5)
92 = ^  1.0 mm in V5 or
^  2.0 mm in any of VI V2 V3 V4
59-61 See page 129 Minnesota Code Summary
Example
981 = technical problems which interfere with coding. 
983 = LVH on voltage criteria, no ST changes.
Angina Studv: Exercise Test Results 
PARTI
Section Number 
Study Number 
Date of test
1. Blood Pressure/Heart Rate Response:
Systolic Diastolic
Resting 14-16 | _ | _ | _ |  29-31
Peak exercise |_|__|__| 17-19 | _ | _ | _ |  32-34
Immediate recovery |_|__|__| 20-22 l _ l _ l _ l  35-37
End recovery |_|__|__| 23-25 l _ l _ l _ l  38-40
Maximum recorded |_|__|__| 26-28 l _ l _ l _ l  41-43
(up to and including 
immediate recovery)
BP response 1 = Normal
2 = Hypotension ( ^ 2 0  mmHg fall)
3 = Hypertensive (>210 and/or > 110)
4 = Other
5 = Not applicable
PART II
Section Number 
Study Number
2. ST segment changes
Hyperventilation/postural changes 1 = Yes 2 = No
If yes: 1 = T wave changes
2 = ST depression
3 = Other (specify...............................
ST depression (modified Minnesota code)
anterolateral (I, aVL, V6)
maximum (mm) 
inferior (posterior) (n,m,aVF) 
maximum (mm)
anterior (VI-5)
maximum (mm)
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ST elevation I__I__I. I__125-27
3. Arrhythmias I_I__| . |__128-30
Specify type..................................................................................  I__I 31
4. Ventricular Conduction Specify......................................................   |__|__| . I__132-34
5. A-V conduction Specify................................................................  I__|__| . |__135-37
6. Total exercise duration (minutes:seconds) I_|__| . |_|__138-41
7. Recovery time for ECG to return to baseline__________________ |_|__| . |_|__142-45
8. Symptoms:
Chest pain during exercise 1 = yes 2 = no I__| 46
Time start |__ | |_|__| . |__|__147-51
Time stop |__ | |_|__| . | __|__152-56
(0 prior to time signifies during exercise)
1 prior to time signifies during recovery)
9. Reason for stopping test (see codes) |__|__157-5 8
Specify...........................................................................................
10. On regular medication? 1 = yes 2 = No |__| 59
(betablocker, calcium antagonist, long acting nitrates)
If yes, medications stopped: |__| 60
0 = not applicable
1 = less than 24 hours prior to test
2 = 24-47 hours prior to test
3 = 48 or more hours prior to test
4 = Not stopped
Study number
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Angina
PARTI
(L
1. BP
Studv: Exercise Test Codes
Box No. Code
1 - 2  01 = Section Number
3 - 7  Study number
8-13 Date of test
Systolic blood pressure
14-16 resting
17 - 19 peak exercise
20 - 22 immediate recovery
23 - 25 end recovery
26-28 maximum recorded
Diastolic blood pressure 
29-31 resting
32 - 34 peak exercise
35 - 37 immediate recovery
38 -40 end recovery
41-43 maximum recorded
Heart rate
44-46 resting
47 - 49 peak exercise
50 - 52 immediate recovery
53 - 55 end recovery
999 = missing
56 BP response:
1 = Normal
2 = Hypotension (fall in systolic 
and/or diastolic BP of > 20mmHg)
3 = Hypertensive (rise in systolic BP > 210 
and/or diastolic BP >110 mmHg)
4 = Other
5 = Not applicable
9 = Incomplete data missing
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PARTE
1 - 2  Section number (02)
3 - 7  Study No.
2. ST changes 8 1 = Yes
2 = No
9 1 = T wave changes
2 = ST depression
3 = Other
Leads ST code
ST depression, 
etc.
10 - 12 Anterolateral (codes 11.1 - 11.9 apply to Box.
I, aVL or V6 Nos 10-12, 15-17 and/or 20-22)
15 - 17 Inferior 11.1 = ST-J depression ^  1.0mm
II, HI or aVF horizontal or downward
sloping and any one of 
these leads
20 - 22 Anterior 11.4 = ST-J depression ^  1.0mm
Vl-5 upward sloping, in one of
these leads.
11.5 = ST-J depression ^  1.0mm 
horizontal or downward 
sloping from baseline 
coded ST depression.
11.6 = Post exercise decrease in 
horizontal/downward 
sloping ST-J depression 
coded at rest, or change to 
upward sloping ST 
depression.
11.7 = No change from resting 
coded ST item.
11.8 = Change from any coded 
ST item at rest to no 
reportable ST item post 
exercise.
11.9 = Questionable ST 
depression post exercise due 
to technical considerations.
00.0 = No codable post exercise 
ST items.
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ST elevation
Maximum measured (mm) horizontal/planar ST
depression (J+60 msec)
0.0 = None/Not applicable
13-14 in anterolateral (I, aVL or V6) leads.
18-19 in inferior (II, in or aVF) leads.
23 -24 in anterior (VI 2 3 4 or V 5) leads.
25 - 27 16.1 = Change from no coded ST elevation at rest
to ST segment elevation > 1.0mm in any lead.
3. Arrhythmias 28 - 30 15.1 = change from no coded arrhythmia at rest to
any reportable arrhythmia post exercise.
Type 31
00.0 = No arrhythmia
1 = frequent (10% or more of recorded complexes)
ventricular premature beats
2 = frequent atrial/functional premature beats
3 = Supraventricular tachycardia (persistent)
4 = Ventricular tachycardia (persistent)
5 = Intermittent VT : three or more ventricular
premature beats at a rate ^  100
6 = Atrial fibrillation (persistent)
7 = Atrial flutter (persistent)
8 = Other
0 = No arrhythmia
4. Ventricular 
conduction
Change from no coded ventricular conduction item 
at rest to :
32 -34 14.1 = complete left bundle branch block
14.2 = complete right bundle branch block
14.3 = incomplete right bundle branch block
88.8 = Other
00.0 = No change
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5. A V Conduction Change from no coded AV conduction item at rest
to:
35-37 13.1 = Complete (third degree)A-V block
13.2 = Partial (second degree) A-V block
13.3 = first degree A-V block (PR > 0.22)
13.8 = Other
00.0 = No change in A-V conduction
6. 38-41 Total exercise duration
38 - 39 minutes
40-41 seconds
7. 42 -45 Recovery time for ECG to return to baseline
42 - 43 minutes
44 - 45 seconds
8. Chest pain 46 1 = Yes
2 = No
Start 47-51 (where > 1 episode, longest recorded)
47 0 = indicates time period up to peak exercise
1 = indicates time period into recovery
48 - 49 minutes
50-51 seconds
Stop 52 - 56
52 0 = indicates time period up to peak exercise
1 = indicates time period into recovery
53 - 54 minutes
55 - 56 seconds
999.99 = data missing
000.00 = not applicable
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9. Reason stopped
57 -58 01 = Leg fatigue
02 = General fatigue
03 = Chest pain
04 = Shortness of breath (dyspnoea, ‘SOB’)
05 = Chest pain and dyspnoea
06 = Dyspnoea due to COAD
07 = ST changes
08 = Intermittent claudication
09 = Hypotension (with or without symptoms)
10 = Dizziness with no drop in BP.
11= Increasing ventricular ectopic activity
12 = Arrhythmia (other than ‘11’)
13 = Disability e.g. OA knees
14 = Other
10. On regular medication
(betablocker, calcium antagonist and/or long acting 
nitrates)
59 1 = Yes 
2 = No
60 If ‘yes’ medications stopped:
0 = not applicable
1 = less than 24 hours prior to test
2 = 24-47 hours prior to test
3 = 48 or more hours prior to test
4 = Not stopped
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APPENDIX 10
CHEST PAIN STUDY 
TAPE HOOK-UP PROTOCOL
Patient undressed to waist; hip bone exposed on left side. 
All hair to be shaved off following positions
Green
\
Black
Red
White
Skin abrasion with gauze and electrode jelly until red (warn patient - may hurt!). 
Wipe with swab and let dry.
Attach electrodes as above (check for adequate R-wave height in V5 on resting ECG; if 
necessary, use exploring electrode to find best position for red electrode).
After forming ‘stress loop’ on wire, each electrode to be secured with ample tape.
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Tracker Tape
Check 24 hour tape clock reads correct time.
Insert battery.
Insert cassette (TDK D90) - Engage head.
Press Calibrate button once - clock will flash until calibrated (Calibration before 
electrodes attached to patient).
Secure tape.
Press ‘Event’ button then patient carries out following manoeuvres, each approx. 30 seconds:
Lies flat 
Stands upright 
Bends to left 
Bends to right 
Hyperventilates
Press ‘Event’ button again. Time at end of manoeuvres to be written down in patient’s 
diary.
To give to patient:
a) Diary with explanation.
b) Instruction leaflet.
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Information for Patients about 24 Hour Tape Monitoring
This tape will record the electrical activity of your heart over one day. It is important 
that you carry on with ALL your usual daily activities and not restrict yourself in any 
way.
If you experience any chest pain or discomfort (or heaviness in the arms) press the 
‘Event’ button demonstrated to you earlier. At the same time, make a note of the time 
of onset of pain in the diary provided.
If this is more than once a day, the same procedure should be carried out on each 
occasion.
The time any spray or tablet is used under the tongue must also be noted.
Please record times of any: (i) strenuous activities.
(ii) time of main meal
(iii) driving/cycling
(iv) long walks
(v) bowel movement
Thank you for your co-operation.
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APPENDIX 11
Angina Studv: 24 hour tape results
PARTI
Study
No
Line
No
Time
Begin End
ST change 
CM5 CM2
Heart Rate 
Pre Onset During
Chest
Pain
l_ o |_ i| M i l . M i l l 1 1 M 1 1 LI. 1 I I  I I 1 1 1 1 1
1-4 5-6 7-10 11-14 15-17 18-20 21-23 24-26 27-29 30
I JI JI M I L II I I  1 1 1 M 1 1 LI. 1 I I  I I 1 1 1 1 1
1-4 5-6 7-10 11-14 15-17 18-20 21-23 24-26 27-29 30
l_0|_3| M I L M i l l 1 1 LI 1 1 LI. 1 I I  I I 1 1 1 1 1
1-4 5-6 7-10 11-14 15-17 18-20 21-23 24-26 27-29 30
l_0|_4 | M I L M i l l 1 1 LI 1 1 LI. 1 I I  I I 1 1 1 1 1
1-4 5-6 7-10 11-14 15-17 18-20 21-23 24-26 27-29 30
l_0|_5 | M I L M i l l 1 1 LI 1 1 LI. 1 I I  I I 1 1 1 1 1
1-4 5-6 7-10 11-14 15-17 18-20 21-23 24-26 27-29 30
l_0|_6| M I L II I I  1 1 1 LI 1 1 LI. 1 I I  I I 1 1 1 1 1
1-4 5-6 7-10 11-14 15-17 18-20 21-23 24-26 27-29 30
I JI JI M I L II I I  1 1 1 LI 1 1 LI. 1 I I  I I 1 1 1 1 1
1-4 5-6 7-10 11-14 15-17 18-20 21-23 24-26 27-29 30
I JIJI M I L M i l l 1 1 LI 1 1 LI. 1 I I  I I 1 1 1 1 1
1-4 5-6 7-10 11-14 15-17 18-20 21-23 24-26 27-29 30
l_0|_9 | M I L M i l l 1 1 LI 1 1 LI. 1 I I  I I 1 1 1 1 1
1-4 5-6 7-10 11-14 15-17 18-20 21-23 24-26 27-29 30
IJLOI M I L II I I  1 1 1 LI 1 1 LI. 1 I I  I I 1 1 1 1 1
1-4 5-6 7-10 11-14 15-17 18-20 21-23 24-26 27-29 30
I JIJI M I L M i l l 1 1 LI 1 1 LI. 1 I I  I I 1 1 1 1 1
1-4 5-6 7-10 11-14 15-17 18-20 21-23 24-26 27-29 30
IJl_2| M I L M i l l 1 1 LI 1 1 LI. 1 1 I I  1 1 1 1 1 1
1^1 5-6 7-10 11-14 15-17 18-20 21-23 24-26 27-29 30
I JIJI M I L M i l l 1 1 LI 1 1 LI. 1 1 I I  1 1 1 1 1 1
1-4 5-6 7-10 11-14 15-17 18-20 21-23 24-26 27-29 30
I JIJI M I L M i l l 1 1 LI 1 1 LI. 1 1 1 I I 1 1 1 1 1
1-4 5-6 7-10 11-14 15-17 18-20 21-23 24-26 27-29 30
I JI JI M I L II I I  1 1 1 LI 1 1 LI. 1 I I  I I 1 1 1 1 1
1-4 5-6 7-10 11-14 15-17 18-20 21-23 24-26 27-29 30
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Section Number |_0|_11 1 - 2
Study Number___________________ I__|__|__|__I 3 - 6
Recording date |__|__|__|__|__|__I 7 -12
1. Trend printout 
Episodes ^  1 mm ST depression on trend:
Episode Number Time of max.STD: mm STD
|_0 _ll 13 - 14 1 — i — 1 — 1 — 1 15-18 | _ | . I _ l  19-20
|_0 J l 21-22 1 _ I___ I____1 1 23 -26 | _ | . | _ |  27-28
|_0 J l 29-30 1 . - 1___ 1____1 _  1 31-34 | _ | . | _ |  35-36
|_0 _4| 37-38 1___ 1 - 1 . . 1__1 39 -42 | _ | . | _ |  43-44
|_0 J l 45-46 1___ 1____1 -  1____1 47-50 | _J . l _ l  51-52
|_0 J l 53-54 1 .. _ 1___ 1____1____1 U
l i 00 L | _ |  59-60
|_0 _7| 61-62 1___ 1____1 . - . 1------1 63 -66 | _ | . | _ |  67-68
|_0 J l 69-70 1 —  1— 1 —  1— 1 71-74 | _ | . | _ |  75-76
Section Number I J I J I  1 - 2
Study Number |__ _ l _ l _ l  3 -  6
l_0 J l 7 -  8 9 - 1 2  | _ | . l _ l  13-14
I_1 J l 15 - 16 1___ 1____ 1____1 - 1 17-20 | _ | . | _ |  21-22
1J _1| 23-24 1___ 1____1____1____1 25 -28 | _ | . | _ |  29-30
I_1 J l 31-32 1___ 1____1____1____1 33 - 36 | _ | . U
i
-J l o
o
I _ 1 _3| 39-40 1___ 1____1____1____1 41-44 | _ | . | _J  45-46
I _ 1 J l 47-48 1___ 1 - 1____1____1 49-52 | _ | . l_ U
l 1 U
l
I _ 1 J l 55-56 57-60 | _ | . | _ |  61-62
Specify reason trend incorrect:
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2. Duration of record I I I-I I |63-66
3. Any significant arrhythmia 1 = Yes
2 = No
67
Type: 1 = Ventricular tachycardia |  | |68-69
2 = Supraventricular tachycardia
3 = Atrial fibrillation
4 = Idioventricular rhythm
5 = Frequent ventricular ectopics
6 = Frequent supraventricular ectopics
7 = L B B B
8 = Two or more types
9 = A - V conduction abnormality 
00 = Not applicable
11 = Other: specify............................
If arrhythmia :
Number of consecutive beats (if < 60s) | | 170-72
If > 60 seconds, total duration in minutes | |73-76
000 = Not applicable
Associated with symptoms? 1 = Yes
2 = No
3 = Sometimes
0 = Not applicable
4. Baseline ST elevation (^  1mm) 
at night > 30 minutes.
1 = Yes
2 = No
| _ |  78
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Section Number | _01 _31 1-2
Study Number |__|__|__|__| 3-6
5. Medication: Any regular beta blockers,
calcium antagonists or nitrates (excluding sublingual)
1 = Yes
2 = No
Type: 1 = Beta blocker
2 = calcium antagonist
3 = regular nitrate
4 = Combination
0 = Not applicable 
If yes, medication stopped prior to recording for:
1 = ^  24 hr
2 = ^  48 hr
3 = Not stopped 
0 = Not applicable
6. Postural/hyperventilation ST changes I__| 10
0 = None
1 = T wave inversion
2 = ST depression
3 = ST elevation
4 = Other
7. Technical suitability: 1 = Yes |__] 11
2 = No (for reason other than ‘3’)
3 = No, Baseline instability affecting analysis
If no, specify:..................................................................................................
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Angina Study : Coding for 24 Hour Tape Results 
PARTI
Box number Code
I-4  Study Number
5- 6 Line Number
7-10 Start time of episode in hours and minutes (24 hour clock)
II-14 End of episode time (24 hour clock)
15-17 mm ST depression from baseline in lead CM5 to one
decimal place (‘9’ in box 15 indicates ST elevation from 
baseline)
00.0 = No ST change
18-20 mm ST depression from baseline in lead CM2 to one
decimal place (‘9’ in box 18 indicates ST elevation)
00.0 = No ST change
99.9 = Not recorded/technically unsuitable
21-23 Heart rate preceeding onset of episode (within 30 minutes)
999 = Not recorded/technically unsuitable
24-26 Heart rate at onset of episode
27-29 Heart rate during episode
000 = Not recorded
30 1 = Anginal chest discomfort
2 = No chest discomfort
7-30 Blank boxes = No episodes
9
999 = missing data
9999
181
Angina Study : Coding for 24 Hour Tape Results (Cont’d) 
PART n
No. Box number Code
1-2 Section number = 01
3- 6 Study number
7-12 Date of recording
13-14
21-22
29-30
37-38 = Trend episode number
45-46 
53-54 
61-62
69-70
15-18
23-26
31-34
39-42
47-50 = Time of max.STD (hours, minutes)
55-58 9999 = No trend printout
63-66 8888 = Trend unreliable due to ‘aberr ants’/wavy base
71-74
19-20
27-28
35-36 = mmSTD in trend
43-44 0.0 = Not applicable
51-52
59-60
67-68
75-76
(15-76 Blank boxes = no trend episodes)
Section 2
!
2. Duration 
of record
3. Arrhythmias
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1-2 Section number = 02
3- 6 Study number
7-8
15-16
23-24 = Trend episode number
31-32
39-40
47-48
55-56
9-12
17-20
25-28 = Time of max.STD (hours, minutes)
33-36 9999 = No trend printout
41-44 8888 = Trend unreliable due to ‘aberr ants’/wavy base
49-52
57-60
13-14
21-22
29-30 = mmSTD in trend
37-38 0.0 = not applicable
45-46
53-54
61-62
(9-62 Blank boxes = No trend episodes)
63-66 63-64 = hours
65-66 = minutes
67 1 = Yes
2 = No
68-69
70-72
73-76
Symptoms 77
4. Baseline ST 78 
elevation
Section 3
1-2
3-6
5. Medication 7
8
1 = Ventricular tachycardia
2 = Supraventricular tachycardia
3 = Atrial fibrillation
4 = Idioventricular rhythm
5 = Frequent ventricular ectopics
6 = Frequent supraventricular ectopics
7 = Left bundle branch block
8 = Two or more types
9 = A-V conduction abnormality 
00 = Not applicable
11 = Other
No. of consecutive beats (if < 60s) 
Total duration in minutes (if > 60s)
000 = Not applicable
1 = Yes
2 = No
3 = Sometimes
0 = Not applicable
1 = Yes
2 = No
0 = Not applicable
Section Number 
Study Number
1 = Yes
2 = No
1 = Beta blocker
2 = calcium antagonist
3 = regular nitrate
4 = combination
0 = Not applicable
96. Postural/hyper- 10 
ventilation
Medication stopped prior recording for
1 = ^  24 hr
2 = ^  48 hr
3 = Not stopped
0 = Not applicable
0 = none
1 = T wave inversion
2 = ST depression
3 = ST elevation
4 = Other
7. Technical 11 1 = Yes
suitability 2 = No (for reason other than ‘3’)
3 = No, Baseline instablity affecting analysis
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Follow-up Questionnaire
PLEASE ANSWER BY PUTTING A TICK (✓) IN 
THE APPROPRIATE BOX AND BY WRITING IN 
THE SPACES PROVIDED
1. Since your visit to the Chest Pain Clinic 
are you now under the care of:
Yes No
(1) Your General Practitioner alone___________ |_|_____|__
or
(2) Your General Practitioner and a
hospital specialist |_| |__
2. Since your visit to the Chest Pain Clinic 
do you still get chest pain?
Yes | _ |  No | _ |
3. Since your visit to the Chest Pain Clinic have you attended 
any hospital outpatient clinic about your heart?
Yes | _ |  No | _ |
If ‘N o’ , please go to Question 4.
If ‘Yes’ , please state:
Name o f Hospital ___________________________
Name o f Consultant ___________________________
What were the main diagnoses:
(i) ___________________________________________
(ii) ___________________________________________
APPENDIX 12
FOR OFFICE USE 
No. | _ | _ | _ | _ |  1-4
I__I_I__I I 5- 8
I_I__ I___ I__I___I I 9-14
I__1__ I___ I__I__ t 115-21
l _ l  22
l _ l  23
l_ l 24
l_ l 25
l_ l 26
l _ l _ l  27-28
l_ l 29 
l_ l 30
(ill) l_ l 31
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4. Since your visit to the Chest Pain Clinic have you been 
admitted to hospital with heart problems?
Yes | | No | _ j  | _ |  32
If ‘N o’, please go to Question 5.
If ‘Yes’, please give the following information for your 
most recent hospital admission:
Name o f Hospital ___________________________  |  | 33
Name o f Consultant ___________________________  | __ | __ | 34-35
Date o f admission Day  Month Y ear |  |  |  |  |  |  | 36-41
What were the main diagnoses?
(0 ________________________________  l_ l 42
(ii) ____________________________________________  l _ l  43
(iii) ____________________________________________  l _ l  44
5. Since your visit to the Chest Pain Clinic have you had a 
Cardiac Catheter test? (Coronary angiography)
Yes |__ | No |__ | | _ |  45
If ‘N o’, please go to Question 6.
If ‘Yes’:
Date o f test Day  M onth  Year  |__ |__ |__ |__ |__ |__ | 46-51
Name o f  Hospital   |__ | 52
Name o f  Consultant ____________________________  |__ |__ | 53-54
What was the result o f your test?
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6. Since your visit to the Chest Pain Clinic has your GP or a  
hospital specialist prescribed treatment for any of the 
following?
Yes No
(1) High blood pressure |__ | |__ j |__ j 56
(2) High blood cholesterol |__ J j__ J j__ j
(3) Diabetes j__ | j__ | |__ | 58
7. Since your visit to the Chest Pain Clinic have you had any Section |_2j 1
o f the following?
No. | _ | _ | _ | _ |  2 - 5
Yes No If ‘Yes’ please state 
Date: Consultant:
(1) Unstable |___| |___|     |___| 6
Angina
l _ l _ l  7 - 8  
I I I I I I I 9-14
(2) Heart attack |  | J | _____    |__ | 15
(myocardial
infarction) |___ |  | 16-17
I I I I I I I 18-23
(3) Balloon | _ |  | _ |  | _ |  24
angioplasty
(PTCA) | _ | _ |  25-26
I I I I I I I 27-32
(4) Coronary | _ |  | _ |      | _ |  33
Bypass
Surgery l _ l _ !  34-35
(CABG)
36-41
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8. Please list the names of any drugs (including tablets or spray 
under the tongue) you are now taking:
Name o f Medication:
1. __________________________________________
2 . _____________________________________________________
3. ________________________________________________________
4. ________________________________________________________
5. ________________________________________________________
6 . _____________________________________________________
7. _______________________________________________________
8. _______________________________________________
9. _______________________________________________________
10 . ____________________________________________________
9. Please state your Hospital number (if known, for example 
from your Outpatient appointment card)
10. Name o f current General Practitioner
Surgery Address
11. Today’s Date ________________________________________
THANK YOU VERY MUCH FOR YOUR TIME AND EFFORT IN  
COMPLETING THIS QUESTIONNNAIRE.
PLEASE RETURN IT IN THE STAMPED ADDRESSED 
ENVELOPE SUPPLIED.
42-43
44-45
46-47
48-49
50-51
52-53
54-55
56-57
58-59
60-61
